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ABSTRACT 
Thrombus formation at blood interfaces is a critical factor 
in the design of medical devices and artificial organs. The thrombo-
genicity of polymers was correlated with protein adsorption data from 
plasma. Surfaces with preferred adsorption of glycoproteins, such 
as fibrinogen and gamma-globulin, over albumin were shown to be more 
thrombogenic. The mole ratio of adsorbed fibriogen or gamma-globulin 
to adsorbed albumin provided an index to the thrombogenicity of the 
polymer surface. 
The mechanisms of platelet interaction and consequent platelet 
adhesion onto polymer surfaces were indirectiy verified by the estab-
lished hypothesis that the glycoproteins with terminal sugar units 
such as galactose or N-acetylglucosamine of incomplete oligosaccharide 
chains may interact with platelets via an enzyme-substrate complex 
formation. The degree of complex formation or platelet interaction 
with glycoproteins, which subsequently affects platelet aggregation 
and release, was determined by varying the number of exposed glactose 
groups at the terminus of oligosaccharide chains. The number of ex-
posed galactose termini was controlled by enzyme treatments of neura-
minidase and galactose oxidase or pe'~iodate treatment. Galactose 
oxidase-treated glycoproteins showed decreased aggregation and releas-
ing activity as well as a weaker interaction with platelets due to 
the decreased number of the inteact terminal galactose groups. Perio-
date treatment, which selectively oxidizes carbohydrate residues 
of the glycoproteins, also significantly reduced the platelet aggrega-
tion and the serotonin releasing activity of the glycoproteins. The 
neuraminidase treatment, by which the increased number of galactose 
groups was exposed at the terminal position of the oligosaccharide 
chains, caused a greater interaction of platelets with the proteins 
followed by an increased serotonin release from the platelets. How-
ever, the increased number of terminal galactose groups failed to 
induce the correspondingly increased aggregating activity. 
The neuraminidase treatment resulted in a conformational 
change arising from removal of sialic acid. This conformational 
change, confirmed by circular dichroism spectra of the protein, may 
be responsible for the nonincreasing aggregating activity of the 91y-
coproteins in spite of the increased terminal galactose groups. Such 
a conformational chang~ could be observed by UV irradiation of the 
glycoproteins which also reduced the aggregating activity of the pro-
teins. Therefore, the involvement of glycoproteins in platelet aggre-
gation may require conformational integrity of the protein for the 
maximal aggregation effect. 
The similar interaction of platelets with the glycoproteins 
was determined from platelet retention experiments using protein-
immobilized beads packed in columns. The retention of platelets, 
when citrated whole blood was passed through the columns containing 
protein-immobilized Sepharose 2B, was increased with increasing num-
bers of terminal galactose residues. r~mobi1ization of galactose to 
beads also significantly increased the platelet retention in the 
galactose-immobilized bead columns. 
v 
The results of the platelet interactions with adsorbed pro-
teins on polymer surfaces were directly observed by scanning electron 
micrography and light micrography. These micrography results showed 
a similar patter1 to the results previously described. An increased 
number of adhered platelets was observed on the neuraminidase-treated 
glycoprotein coated polymer surface, while platelet adhesion was 
markedly decreased on the galactose oxidase-treated or the periodate-
treated glycoprotein coated surface to a level equal to that of al-
bumin coated surfaces. 
The use of sialyltransferase inhibitors, such as aspirin and 
UDP, depressed ADP-induced platelet aggregation. The results obtained 
are supportive of the involvement of this proposed enzyme mechanism 
for platelet-protein interactions. 
vi 
CONTENTS 
ABSTRACT . . . 
LIST OF TABLES 
LIST OF FIGURES 




INTRODUCTION . . . . . 
BLOOD GLYCOPROTEINS 
2.1 Structural Nature of G1ycoproteins 
2.2 Fibrinogn ............ . 
2.2.1 Structure and Physicochemical 
Properti es . . . . . . . . . . . . . . . . . 
2.2.2 Carbohydrate Structure of Fibrinogen. 
2.3 Gamma-globulins .............. . 
2.3.1 Structure and Conformation (95,97,98). 
2.3.2 Carbohydrates of Gan~a-globulins . 
2.3.2.1 IgG immunoglobulin ..•. 
2.3.2.2 IgA immunoglobulin 
2.3.2.3 19M immunoglobulins .... 
PROPOSED MECHANIS~1 OF PLATELET AGGREGATION AND 



















3.1 Enzyme Reaction of Two Substrates (121,122) . 40 
4 
5 
3.2 Proposed Nechani sm . . . . . . . . 42 
PLATELET AGGREGATION AND RELEASE . . . 49 
4.1 Aggregation and Release. . . . . . . . . . . 49 
4.2 The Involvement of Plasma Proteins in Plate-
let Aggregation and Release . . . . . . . . . . . 51 
CIRCULAR DICHROISM: THEORY AND ITS APPLICATION 
TO ANAL YSIS OF PROTEIN CONFORt1ATION 




5.2 Application of Circular Dichroism to An 




6.1 Preparation of Materials. . . . 62 
6.1.1 Quantification of Plasma Proteins. 62 
Reagents .......... . . . . 62 
6.1.1.1 Total Protein in Plasma (182) 63 
6.1.1.2 Gamma-globulin in Plasma 
( 183 , 184) • • • • . . . • • • . • . • • • 63 
6.1.1.3 Fibrinogen in Plasma (185,186) . 64 
6.1.1.4 Albumin in Plasma (Methyl Orange 
Binding) (187) ............. 65 
6.1.2 Purification of Fibrinogen . . . . . . 65 
6.1.3 Immobilization of Proteins to Sepharose 
Beads (189). . . . . . . . . . . . . . . . . . 67 
6.1.3.1 Fibrinogen, Gamm-globu1in, and 
Ablur.1in . . . . . . . . . . . . . . . . . 67 
6.1.3.2 Enzymes (Lactoperoxidase, Galac-
tose Oxidase, and Neuraminidase) 69 
6.1.4 Enzymatic Radioiodination of Plasma 
Protei ns . . . . . . . . . . . . . . . . . . . 70 
6.1.5 Enzyme Treatment of Proteins ..... 72 
6.1.6 Soldium Periodate Treatment of Proteins 77 
6.1.7 Preparation of Platelet Rich Plasma 
(PRP) and Washed Platelets. . . . . . . . . . 78 
6.1.8 Platelet Counting. .......... 80 
6.1.8.1 Phase Contrast ~1icroscopy (209). 80 
6.1.8.2 Coulter Counter (210) . . . . . 80 
6.1.9 Immobilization of D-Galactose to Sepha-
rose 28. . . . . . . . . . . . . . . . . . . . 82 
6.1.9.1 Preparation of a S-D-Galacto-
pyransosylamine (211,212) . . . . . . . . 82 
6.1.9.2 N-3enzyloxy carbony1-E-amino-
caproic acid (213) .... . . . . . . . 82 
6.1.9.3 Preparation of N-(N-Benzyloxy 
carbonyl-E.-Amino caproy1)-ga1actopyran-
osylamine (211) . . . . . . . . . . . . . 84 
6.1.9.4 Preparation of ti-s-Amino 
caproyl -S-D-galactopyransolylamine (211) 84 
6.1.9.5 Immobilization of N-s-A~ino 
caproyl-8-D-galactopyransoylamine to 
Sepharose 2B (189) ........... 85 
6.1.10 Degradation and Denaturation of 
Fi bri nogen . . . . . . . . . . . . . . . . . . 85 
6.2 Adsorption of Plasma Proteins Onto Various 
Polymer Surfaces . . . . . . . . . . . . . . . 86 
6.3 Interaction of Platelets with Plasma Glyco-
protei ns . . . . . . . . . . . . . . . . . . . 88 
viii 
6.3.1 Filtration Method. . . . . . . . . 88 
6.3.2 Sedimentation Method . . . . 39 
6.4 Serotonin Release (215) .... . . . . 89 
6.5 ADP-Induced Platelet Aggregation (216) . 90 
6.6 Retention of Platelets in the Protein- and 
Galactose-immobilized Sepharose 2B Columns . . . . 92 
6.7 Light and Scanning Electron Micoscopy . . . . 92 
6.8 Circular Dichroism Measurements 93 
7 RESULT AND DISCUSSION .... 95 
7.1 Protein Adsorption. . . . . . . . 95 
7.2 Interaction of Platelets with Glycoproteins 103 
7.3 Serotonin Release . . . . . . . . . . . 113 
7.4 ADP-Induced Platelet Aggregation. . . . . . . 119 
7.5 Retention of Platelets in the Protein- and 
Galactose-Immobilized Beads in Columns . . . . . . 133 
7.6 Platelet. Adhesion onto Protein-Coated Surfaces 138 
7.7 Circular Dichroism. . . . . . . . . . . 151 
7.8 Involvement of Enzyme Reaction Mechanism in 
Platelet Aggregation, Adhesion, and Release 158 
8 SUMMARY AND CONCLUSIONS . . 162 
REFERENCES 167 














LIST OF TABLES 
Carbohydrate Composition of Human Immunoglobu~ 
1 ins . . . . . . . . . . . . . . . . . . . . 
Protein Adsorption from Human Plasma at 37°C . 
Mole Ratio of Adsorbed Fibrinogen to Adsorbed 
Ablumin .................. . 
Mole Ratio of Adsorbed y-G1obulin to Adsorbed 
A 1 bum in. . . . . . . . . . . . . . . . . . . . . 
Relative Binding Percent of Native and Enzyme-
Treated Fibrinogen and y-Globulin with Platelets. 
Binding of Native and Enzyme-Treated Fibrinogen 
with Washed Bovine Platelets .......... . 
Binding of Native and Enzyme-Treated y-Globulin 
with Washed Bovine Platelets .......... . 
Effects of Proteins of Various Concentrations on 
the Release of 14C-Serotonin .......... . 
Effects of Natiye and Enzyme-Treated Proteins on 
the Release of 4C-Serotonin ......... . 
Percent Release of Serotonin from Bovine-Washed 
Platelets by NaI04 Treated Proteins ...... . 
Circular Dichroism (CD) Parameters of UV and 
Enzyme-Treated Fibrinogen in the Far Ultraviolet 
Region ............... , ..... . 
Circular Dichroism (CD) Parameters of Periodate~ 






























LIST OF FIGURES 
Sugar units of blood glycoproteins ....... . 
Three representative linkages between oligosaccha-
rides and peptide chain backbones ....... . 
Schematic model of the dimeric fibrinogen molecule 
wi th two-fo 1 d ax is of symmetry . . . . . . 
Disulfide bridges in N-OSK 
Depictions of fibrinogen and fibrin as derived 
from various electron microscopy studies ... 
Possible structure of the sugar chains in fibrino-
gen . . . . . . . . . . . . . . . . . . . . 
Schematic representation of an immunoglobulin mole-
cu 1 e . . . . . . . . . . . . . . . . . . . . . . . 
Schamtic representation of an 19G molecule showing 
the point of cleavage by papain and pepsin in the 
hinge region and the origin of the various frag-
ments . . . . . . . . . . . . . . . . . . . . . . 
Schematic portrayal of the distribution of carbo-
hydrate units ............ . 
The structure of the IgG immunoglobulin glycopep-
tides .................. . 
The carbohydrate units of 19A immunoglobulin .. 
Schamtic diagram of the polypeptide structure of 
a monomeric unit of the human 19M macroglobulin 
Ou . . . . .. • . . . . It , • • .. • • • • • • 
The structures of the IgM glycopeptides 
Synthesis of the terminal trisaccharide units in 
serum glycoproteins ...•.... ~ .••... 
The proposed mechanism of platelet adhesion onto 



































Activation of Sepharose beads ....... . 
Immobilization of protein to activated beads 
The elution diagram of gel filtration of I125_ 
labelled fibrinogen ...... . 
Enzyme treatment of glycoproteins .. 
Immobilization of galactose to Sepharose 2B 
Schematic diagram of static adsorption of pro-
te ins . . . . . . . . . . . . . . . . . . . . . . 
Schematic diagram of the procedure for serotonin 
release .................... . 
Adsorption of albumin from human plasma on vari-
ous polymer surfaces ... . . . . . . 
Adsorption of y-Globulin from human plasma on 
various polymer surfaces . . . . . . . . . . 
Adsoprtion of fibrinogen from human plasma on 
various polymer surfaces ......... . 
Binding of native and enzyme-treated fibrinogen 
to washed bovine platelets .......... . 
Binding of native and enzyme-treated y-globulin 
to washed bovine platelets ........ . 
Double reciprocal plots of fibrinogen binding 
with platelets .............. . 
Double reciprocal plots of y-g1obu1in binding 
with platelets ........... . 
Dependence of protein-induced serotonin release 
upon concentration of proteins ...... . 
Effects of native and enzyme-treated proteins on 
the release of l4C- serotonin . " ~ .•... 
Release of l4C-serotonin from washed bovine 
platelets by NaI04-treated proteins. , t ~ 
Effects of native and enzyme~treated fibrinogen 
on ADP-induced aggregation df washed bovine 




































Effects of native and enzyme-treated y-globulin 
on ADP-induced aggregation of washed bovine 
platelets ................... . 
Effects of periodate-treated fibrinogen on ADP-
induced aggregation of washed boinve platelets 
Effect of periodate-treated y-globulin on ADP-
induced aggregation of washed bovine platelets 
Effect of U.V. treated fibrinogen on ADP-induced 
aggregation of washed bovine platelets ..... 
Effect of U.V. treated y-globulin on ADP-induced 
aggregation of washed bovine platelets ..... 
Effect of plasmin treated fibrinogen (Fragments, 
o + E) on ADP-induced aggregation of washed 
bovine platelets ............. . 
Effect of drugs on ADP-induced aggregation of 
bovi ne PRP . . . . . . . . . . . . . . . . . . . 
Platelet retention in fibrinogen-immobilized 
Sepharose 28 columns ........... . 
Platelet retention in y-globulin-immobilized 
Sepharose 28 columns ........... . 
Platelet retention in galactose-immobilized 
Sepharose 28 columns .......... . 
Scanning electron micrograph of platelet adhe-
sion onto albumin coated j"ylar surface ..... 
Light micrograph of platelet adhesion onto albu-
min coated Mylar surface ........... . 
Scanning electron micrograph of platelet adhe-
sion onto fibrinogen coated r~lar surface .... 
Scanning electron micrograph of platelet adhe-
sion onto f4ylar surface coated \"I;th ~'Jeurarnini­
dase-treated fibrinogen ...........•. 
Scanning electron micrograph of platelet adhp-
sion onto nylar surface coated vIJith galactose 
oxidase treated fibrinogen ..... " •• \ . 
Scanning electron micrograph of platelet adhe~ 































Scanning electron microqraph of platelet adhe-
sion onto t"1ylar surface coated \v;th neuraminidase 
treated y-globulin .............. . 
Scanning electron micrograph of platelet adhe-
sion onto Mylar surface coated with Galactose 
oxidase-treated y-globulin: lOOOx 
Light micrograph of platelet adhesion onto fibrino-
gen coated :vlyl ar surface . . . . . . . . . . . . . 
Light micrograph of platelet adhesion onto Mylar 
surface coated with neuraminidase-treated fibrino-
g en . . . . . . . . . . . . . . . . . . . . . . . 
Light micrograph of platelet adhesion onto r~lar 
surface coated with galactose oxidase~treated 
fi bri nogen . . . . . . . . . . . . . . . . . . . . 
Light micrograph of platelet adhesion onto 
y- 9 10 bu 1 i n coa ted j,1yl a r surface . . . . . 
Light micrograph of platelet adhesion onto 
y-globulin coated t-1ylar surface ..... 
Light micograph of platelet adhesion onto r~ylar 
surface coated with neurominidase-treated y-globu-
1 in. . . . . . . . . . . . . . . . . . . . . 0 • 
Light micrograph of platelet adhesion onto r~lar 
surface coated with galactose oxidase-treated 
y-globulin ................... . 
Light micrograph of platelet adhesion onto }~lar 
surface coated with periodate-treated fibrinogen 
(1 Hour) .................... . 
Light micrograph of platelet adhesion onto r~lar 
surface coated with periodate-treated fibrionogen 
(2 Hour) .... 0 • 0 0 •• 0 •••••••••• 
Light micrograph of platelet adhesion onto i~lar 
surface coated with periodate-treated y-globulin 
(1 Hour) .................... 0 
Light micrograph of platelet adhesion onto f1ylar 
surface coated with periodate-treated y-globulin 






















Light micrograph of platelet adhesion into non~ 
protei n coated ~o'yl ar surface ~ . . "0 • • • • • • • 
Light micrograph on platelet adhesion onto 
neuraminidase-treated nonprotein coated rWlar sur-
face ~ . . . . . · . · · . >II' • • • • • • • • • • • 
Light micrograph of platelet adhesion onto galac-
tose oxidase-treated nonprotein coated t~lar sur-
face . . . . . . . . . . . . . . . . . . . . . . . 
SEM of platelet adhesion onto nonprotein coated 
~1ylar surface .............. . 
Circular dischroism spectra of native and UV 
treated fibrinogen .......... . 
Circular dichroism spectra of native and enzyme-
treated fibrinogen ............... . 
Circular dichroism spectra of periodate-treated 










This work was supported by National Institute of Health Grant 
HL-17623. 
Grateful thanks are extended to Dr. Sung Wan Kim for his di-
rection and assistance throughout this work. I also wish to express 
my appreciation to Mr. James McRea and Dr. Sung Ho Kim who helped me 
in preparing this manuscript. Thanks is also extended to the members 
of my supervisory committee for their advice and discussions. 
Last, I wish to thank my wife for her patience and encourage-
ment. 
1. INTRODUCTION 
During the last decade there has been a great deal of effort 
in the development of prostheses, such as vascular grafts, heart 
valves, etc., as well as extracorporeal blood treatment devices, such 
as the artificial kidney and the artificial lung. Thrombus formation 
at blood interfaces has been a critical factor in the design of most 
of these devices. When blood comes in contact with a foreign surface 
the initial microscopic events are platelet adhesion and aggregation, 
which lead frequently to local thrombosis and resultant embolism in 
the human body. It is known that thromboembolism is the major cause 
of postoperative morbidity after implantation of artificial heart 
valves (1,2). Platelet thrombosis is also predominant in the eventual 
occlusion of synthetic and autogenous arterial grafts, whose long-
term patency has been correlated with the platelet adhesiveness of 
the patients (3,4). Thrombus formation can be associated with several 
factors: patient thrombus generating potential, surface properties 
of material contacting blood (5), and fluid mechanical stresses exist-
ing in artificial organs (6). The thromboembolic complications accom-
panying the use of such prosthetic devices are due largely to the 
poor hemocompatibility of the surfaces of the constituent materials 
in contact with the blood. Thus, the compatibility of nonbiological 
materials with blood has become a problem of ever-increasing impor-
tance since the advent of cardiac and vascular prosthetic surgery 
2 
(7,8). The search for biomaterials more compatible with blood is 
continuously being made, but it is noticeably hampered by the lack of 
understanding of the complex events involved in the interactions of 
blood with foreign surfaces. Some attempts have been made to corre-
late blood compatibility with the critical surface tensions of syn-
thetic polymers, but without success (9,10). The concept of inter-
facial free energy has also been introduced to predict thrombogenicity 
of synthetic polymers (12), since according to this concept, minimal 
free energy could bring about optimal biocompatibility by minimizing 
protein adsorption. 
Numerous studies have emphasized plasma protein adsorption 
and subsequent platelet adhesion onto polymer surfaces to elucidate 
the mechanism of thrmobosis at the blood-polymer interface. In addi-
tion, results have reported that thrombosis may be induced through 
the decrease of intercellular cyclic adenosine monophosphate (cAMP) 
(13,14), the rapid adsorption and desorption of denatured thrombin 
(15), hemolysis of red blood cells (16), adhered white blood cells 
(17), surface activation of intrinsic coagulation factors (18,19), 
and/or the release of adsorbed fatty acid (20). The adsorption of 
plasma proteins has been considered to be possibly involved in the 
initial stages of blood interaction with implanted materials. Thus, 
the adsorption of pla~ma proteins onto artificial surfaces has been 
investigated extensively using a variety of techniques. Vroman and 
Adams have used a recording ellipsometer to monitor the amount and 
rate of protein adsorbed at a solid-plasma interface (21). Electron 
3 
microscopy has been used to count direclty individual fibrinogen 
molecules adsorbed onto mica surfaces (22). Internal reflection in-
frared spectroscopy has been utilized to obtain adsorption isotherms 
and kinetics on various hydrophobic polymer surfaces (23). Radio-
actively labelled proteins were also used for the studies of competi-
tive adsorption from buffer or plasma (24,20). 
Baier and Dutton have shown that proteins are rapidly adsorbed 
after blood exposure (25). Platelet adhesion to a surface may require 
a protein cofactor, presumably as an intermediate bridging layer. 
Electron micrographs reveal that an external coat of platelet cells 
may participate in the formation of a bridge to a substrate (26,27). 
Polymers exposec to blood ~ vivo adsorb a morphoiogically featureless 
coating layer which is probably significant in the subsequent adhesion 
reaction of platelets upon contact with a surface (25,28). There is 
much other supportive evidence that fibrinogen as well as gamma-
globulin can serve as a cofactor for platelet adhesion (29,31). It 
has also been demonstrated that platelets show little adherence to 
albumin coated surfaces, while fibrinogen or gamma-globulin coated 
surfaces have shown a large number of adhering platelets (30). It 
was reported that a glass surface required a fibrinogen precoat for 
platelet adhesion (32). Similarly, Mason et al., indicated that 
f~ibrinogen is necessary for platelets to adhere to glass; this was 
confirmed with electron microscopy studies (33). Platelets tend to 
interact with radioactively labelled fibrinogen and gamma-globulin 
in plasma, but not with albumin. It was noticed that fibrinogen 
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proteolysis causes the inhibition of platelet adhesion to glass by 
adsorption or binding of fibrinogen digestion products to the plate-
lets (34,35). It is more likely that fibrinogen is presumably more 
effective in bridging the platelets to surfaces. 
Preadsorbed gamma-globulin has also been shown to induce 
platelet release as well as adhesion (30). Fibrinogen has been known 
to cause ADP-induced platelet aggregation (36), platelet spreading on 
glass surfaces, and the late stages of platelet metamorphosis (37). 
Vermylen, et al., (38) showed that both afibrinogenic platelets and 
washed platelets required fibrinogen for aggregation and that small 
concentrations of human fibrinogen were sufficient to restore aggre-
gation by ADP in afibrinogenic subjects. Immunoglobulin G also in-
creases platelet susceptibility to aggregation by ADP (38,39). 
Recently, Brash and Uniyal proposed that an indication of 
thrombogenicity may be available from the adsorbed fibrinogen to al-
bumin mole r'atio. Higher ratios are seen with glass and collagen 
which are more thrombogenic (40). 
The studies mentioned above suggest the involvement of speci-
fic interactions between platelets and glycoproteins such as fibrino-
gen and gamma-globulin in either the bulk or adsorbed states. 
As a physical approach, several investigators have been con-
cerned with the conformational changes.of adsorbed proteins as rela-
ted to platelet adhesion and thrombosis. Nyilas, et al., (41) have 
shown that gamma-globulin molecules in the first adsorbed layer under-
go substantial conformational changes, according to microcaiorimetric 
data. Circular dichroism was utilized by McMillin and Walton to study 
the conformation of fibrinogen and factor XII adsorbed on quartz 
(42). They determined the extent of actual conformational changes 
on adsorption. Morrissey and Stromberg (43), using IR techniques, 
have studied the conformation of prothrombin, serum albumin, and 
fibrinogen in adsorbed states. The results suggest that conforma-
tional changes or rearrangements upon adsorption are minimal. 
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As a biochemical approach, a mechanism for platelet adhesion 
to a polymer was proposed recently in our laboratry (44,45) in which 
platelets adhere to a glycoprotein coated surface via the formation 
of a~ enzyme-substrate complex bridge specifically between the plate-
let membrane bound glycosyltransferases and the incomplete heterosac-
charide present in the surface adsorbed glycoproteins. Fibrinogen 
and gamma-globulin (mainly IgG immunoglobulins) contain oligosac-
charide chains of the same structural patterns (46): N-acetylneura-
minic acid (or fucose) ~ galactose ~ N-acetylglucosmine ~ 
mannose ~ N-acetylglucosmine ~ amino acid asparagine. The oli-
gosaccharides are heterogeneous in their composition of sugar residues 
and terminal residues to achieve incomplete heterosaccharide chains. 
Albumin does not contain such oligosaccharide chains. 
Such an enzyme-substrate complex was previously proposed as a 
general mechanism for cell adhesion in which the glycosyltransferases 
on a cell interact with a glycoprotein acceptor in another cell to 
form an enz~ne mediated complex (47). Platelet adhesion and disad-
hesion between cells were described using this concept of 91yco-
syltransferases forming a complex with the substrate (48). A mech-
anisM for platelet adhesion to collagen was proposed involving similar 
6 
enzyme mediated complexes with glycosyltransferases present on the 
outer surface of the platelet membrane forming a complex with incom-
plete carbohydrate chains in collagen (49,50). Other workers have 
found that platelet aggregation by collagen can be prevented by oxi-
dation of the 6-hydroxymethyl group of the galactose terminal residue 
of the oligosaccharide chains to aldehyde using galactose oxidase. 
Platelet aggregation resumes after reduction of the aldehyde group 
with sodium borohydride (51). 
The role of glycoproteins, such as fibrinogen and gamma-
globulin, in platelet adhesion, aggregation, and release seems to be 
very important and most likely due to the ability of the molecules to 
form such enzyme medicated complexes with platelets. However, little 
study has been done on the role of oligosaccharides in platelet adhe-
sion, aggregation, and release. Furthermore, a detailed understanding 
for the proposed mechanism of platelet adhesion on foreign surfaces 
is necessary. 
The objectives of this thesis are to verify the importance of 
the oligosaccharide groups, especially the terminal sugar residues of 
the oligosaccharides, in platelet interaction and subsequent thrombo-
sis. The extended studies would provide strong evidence for the pro-
posed mechanism involved in platelet adhesion and aggregation. 
This dissertation includes the binding of fibrinogen and gamma-
globulin with platelets, platelet aggregation and platelet retention 
on various protein immobilized beads, The study of platelet release 
induced by the glycoproteins was done using both native proteins and 
those whose oligosaccharide groups were modified enzymatically or 
chemi ca lly . 
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In Chapter 2, blood glycoproteins, the structure and physico-
chemical nature of fiby';nogen and gamma-globulin are reviewed. The 
proposed mechanism of platelet adhesion to foreign surfaces is dis-
cussed in detail in Chapter 3. General concepts of platelet aggrega-
tion and release are reviewed in Chapter 4. Chapter 5 is a brief in-
troduction to the theory and application to analysis of protein con-
formation using circular dichroism. 
The experimental section, Chapter 6, describes preparation of 
materials and conditions of experiments, and Chapter 7 presents the 
results which are discussed in connection with the proposed mechanism. 
Conclusions are stated in Chapter 8. 
2. BLOOD GLYCOPROTEINS 
2.1 Structural Nature of Glyccproteins 
Glycoproteins occur widely in nature and consist of protein 
containing oligosaccharides. The protein component consists of amino 
acid units linked by preptide bonds and the oligosaccharide includes 
sugars joined by glycosidic linkages. Although as many as 100 single 
unit sugars are known, only seven such monosaccharides have been 
found to form the branched oligosaccharide chains of blood glycopro-
teins. The seven sugars are sialic acid (N-acetylneuraminic acid), 
galactose, mannose, N-acetylglucosamine, fucose, glucose, and N-
acetyl-D-galactosamine (Figure 1). 
Most of the plasma proteins which have been isolated and 
characterized in their pure form are glycoproteins, which constitute 
the major portion of the plasma proteins. The remainder are carbo-
hydrate-free proteins and include: prealbumin, albumin, retinal bind-
ing protein and trace amounts of others. The serum contains about 
57 percent carbohydrate-free proteins due to the abundance of albumin. 
The carbohydrate content of the proteins varies from about three per-
cent in IgG up to 38 percent in the al-acid glycoproteins. 
The oligosaccharide groups of most glycoproteins are covalently 
attached to the R groups of specific amino acid residues in the poly-
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Figure 1. Sugar units of blood glycoproteins, 
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glycoproteins (Figure 2). In some glycoproteins, including ovalbumin 
and immuno-globulins, the oligosaccharide is attached via a glyco-
sylamine linkage between N-acetyl-D-glucosamine of the oligosaccharide 
to the amide nitrogen of an asparagine residue in the poly peptide 
chain. 
In the second class of glycoproteins, including the submaxil-
lary mucoproteins, there is an O-glycosidic bond between N-acety1-D-
galactosamine of the side chain oligosaccharide and the hydroxyl 
groups of a serine or threonine residue. This linkage is unusual in 
plasma glycoproteins and is present in immunoglubulins like IgA, IgO, 
and rabbit IgG (53). 
In the third class of glycoproteins, including collagen, the 
oligosaccharide side chains are attached to the hydroxyl groups of 
hydroxylysine residues. The galactose-hydroxylysine linkage has been 
demonstrated in plasma glycoproteins like C1 q (54). 
The structures of oligosaccharides show three patterns in 
plasma glycoproteins. Two of these are N-glycosidically linked and 
can be further subdivided into simple and complex. The simple oli-
gosoccharide unit contains just mannose and N-acetylg1ucosamine. 
This pattern has been found in immunoglobulins (Figure 2). Many dif-
ferent structures have been proposed for this simple pattern of oli-
gosaccharide units. The complex units which tend to be highly 
branched usually contain sialic acid, fucose, galactose, N-acetylgluco-
samine, and mannose. This complex type of oligosaccharide unit has 
been found in most plasma glycoproteins. There is general agreement 
o 
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Figure 2. Three representative linkages between oligosaccharides 
and peptide chain backbones; G1cNAc, N-acetylgluco-
samine; Ga1NAc, N-acety1galactosamine; Glc, glucose; 
Gal, galactose; .t\sn, asparagine; Ser, serine; Thr, 
threonine; Hy1ys, Hydroxylysine. 
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about the peripheral trisaccharide structure of the complex units of 
oligosaccharides: 
NAN A 2 ~ 2/3/4/6 Gal 1 ~ 4 GlcNAc ~ where NANA, Gal 
and GlcNAc are N-acetylneuraminic acid (sialic acid), galactose and 
N-acetyl glucosamine respectively connected between the numerically 
designated carbons. But there is some controversy about the structures 
of the core region of the complex oligosaccharide units. It is gen-
erally agreed that the core structures contain two N-acetylglucosamine 
residues although the mannose content varies from 3 to 4 sugars de-
pending on the glycoprotein. The peripheral trisaccharide units are 
usually attached to the mannose residues of the core region, either 
to those in a terminal position or to internally located mannose 
residues. Few investigations have been carried out on the structure 
of O-glycosidically linked oligosaccharide units. A g1ycoprotein, 
IgAl was found to have five units of oligosaccharides O-glycosidically 
attached to serine in its hinge region (55). One of these consists 
of only GalNAc whereas the other four have the structure: Gal 1 ~ 
3 GalNAc Ser. A similar unit occurs in the hinge regien of rab-
bit IgG (56). 
All glycoproteins show heterogeneity in their composition, 
structure, and attachment sites to peptide backbone. Compositionai 
heterogeneity may affect either the core region of the units or the 
peripheral residues. Peripheral- or micro-heterogeneity affecting 
the sialic acid residues has been detected by electrophoresis or 
isoelectric focusing. This microheterogeneity is associated with in-
complete oligosacchardie groups. There are a number of plasma 
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glycoproteins in which the sialic acid content is much less than 
that of galactose, which unles it is blocked by fucose, is likely to 
be in a terminal position. The extreme example of this is the sialic 
acid-free Sl-glycoprotein containing almost eight percent galactose, 
but possesses no sialic acid and only one percent fucose. 
2.2 Fibrinogen 
2.2.1 Structure and Physicochemical 
Properties 
It is known that fibrinogen in normal blood consists of a 
population of slightly different molecules, which are generally cate-
gorized as low-, intermediate-, or high-solubility in ethanol-water 
mixtures (57). The fibrinogen of low solubility forms complexes VJith 
cold insoluble globulins (58) and its molecular structure is not well 
understood. The highly soluble fibrinogen has a lower molecular 
weight and is most likely produced by limited proteolysis of fibrino-
gen with intermediate solubility by plasmin and/or thrombin (50,60). 
The structure of the intermediate solubility fibrinogen has been 
studied mainly by B10mback and his coworkers (61,62). 
Fibrinogen is known to be a dimer built by two identical 
halves. Each half consists of three polypeptide chains: a(A),6(B), 
and Y, which are linked by disulfide bridges. The two halves are also 
joined by disulfide bonds, Each chain has a free -COOH terminal group. 
The N-terminals of fibrinogen a(A) chains vary with a decided pre-
ference for alanine or threonine depending on species. Alanine or 
aspartic acid is typical for human fibrinogen, but glutamic acid is 
dominant in bovine fibrinogen. Although a wide variety of residues 
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exist at the amino terminals of the 3(8) chains from various species, 
a disproportionate number of a pyrrolidone carboxylic acid (or pyro-
glutamic acid) has been found to block the free H2N- group. Most 
mammalian Y -chains have a tyrosine residue as the N-terminal residue. 
The molecular weight of fibrinogen has been calculated by 
several methods. Based on diffusion and sedimentation (63,64,65) 
characteristics, the molecular weight has been estimated at a range 
of 320,000 to 400,000. The presently accepted value of 340,000, ob-
tained by osmotic pressure measurement (66), is in relatively good 
agreement with light scattering values obtained for fibrinogen from 
several species, i.e., man, ox, sheep, and goat (67,63,68), but horse 
fibrinogen seems to be somewhat larger (67). The molecular weight of 
the chains has also been determined by sedimentation equilibrium (69): 
(A) 63,500, (8) 56,000, and (y) 47,000. Similar values have been 
obtained by 5DS-gel electrophoresis: 64,000, 57,000, and 48,000 res-
pectively (70). The molecular weight of 340,000 as determined for 
fibrinogen gives the formula [a(A), S(b), Y]2 (Figure 3). 
The sedimentation constant (S20,w) for human and bovine fibrino-
gen is in the range of 7.6- 8.5 Svedberg units. The partial specific 
-
volume (V) for human is 0.705- 0.718 and intrinsic viscosity (n) is 
0.23- 0.25 for both species (71). 
A11 the chains in fibrinogen molecule are linked by disulfide 
bonds to conserve the tertiary structure of fibrinogen, From amino 
acid analysis, fibrinogen has been reported to have 28 to 29 disulfide 
bonds (72). There are two kinds of disulfide bridges (62) (Figure 4). 





Figure 3. Schematic model of the dimer;c fibrinogen molecule 
'!lith two-fold axis of symmetry. Th;thrombin. Arrow 
indicates cleavage site of thrombin. The crosslinks 
in black are "stable ll disulfides and the lighter 
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Figure 4. Disulfide bridges in N-DSK 
.. Stable; intermonomer, i.e., symmetric bridges. 
l1li stable; interchain bridge. 
r::::J labile; interchain and intrachain bridges. 
(from reference 62). Used by permission. 
includes one disulfide between a(A)- and B(B)-chain fragment and 
three symmetric disulfides: one between Cys28 of one a(A)- chain 
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and the same residue of another, two disulfides between Cys8 and Cys9 
of one Y-chain and the corresponding residues of the other Y-chain. 
Fibrinogen subjected to cyanogen bromide (CNBr) degradation results 
in an H2N- terminal fragment containing only 40 percent of the origi-
nal sulfur content of fibrinogen. This fragment is called the N-
terminal disulfide knot (N-OSK). Other degradation products contain-
ing disulfide knots wnich are called Hl-OSK, H2-0SK, and H3-0SK are 
hydl'ophobic fragments different from N-OSK. The N-OSK fragment has 
been studied in terms of its molecular weight, amino acid sequence, 
and immunological properties by Blomback and his coworkers (61,62). 
N-OSK subjected to thrombin digestion releases the fibrinopeptide A 
and B exactly like the intact fibrinogen in the process of thrombin 
activated clotting. 
Fibrinogen subjected to plasmic digestion gives fragment D, 
E, and mixture of A, B, and C. Fragment E is a dimeric structure and 
contains considerable amounts of disulfides. A major portion of frag-
ment E is located in the domain of N-OSK and minor portion of frag-
ment 0 is also in this area of the molecule. Immunological study 
has indicated that N-OSK and other hydrophobic DSK fragments are 
buried in the native fibrinogen. 
Based on electron microscopic observations~ several conforma-
tional models for fibrinogen structure have been proposed (7 76) 
(Figure 5), among vJhich the "three-nodular l' model proposed by Hall 


















































































































































































































































fibrinogen molecule is depicted as being composed of three nodular 
balls held together by very slender strands. The two outer spheres 
o 0 
are about 60 A in diameter, while the center sphere is about SO A. 
o 0 
The interconnecting structures are lS A in width and about lSO A in 
length. The total length of most molecules is estimated at about 
o 
450 - 500 A at PH 9.S. The molecule has the shortest length, about 
o 
230 A at the isoelectric point, calculated to be PH S.S, and the 
length increases again below or above PH S.5 (77). Small angle X-Ray 
scattering experiments (78) are not consistent with the Hall and 
Slayter model, yet this model is in excellent agreement with the pat-
tern of fragments produced by plasmin degradation. Other nodular 
models obtained from electron microscopy were too long or too short. 
Koppel's model (76) is different from the nodular models. It 
considers the general form of a pentagonal dodecahedron formed from 
the interwoven strands of the six constituent polypeptide chains. 
This model gives good agreement with the small angle X-Ray scattering 
experiments, but this model cannot be correlated directly to the 
plasmin degradation products. 
Optical rotation (79,80), circular dichroism (81), and low 
angle X-Ray diffraction (82) studies indicated that native fibrinogen 
has a helical content of about 35 percent, which is reduced to 20 per-
cent by alkali, acid, and 5M urea denaturation, and disappears com-
pletely at 5M guanidine HCl or 10M urea 
2.2.2 Carbohydrate Structure of Fibrinogen 
Carbohydrate in fibrinogen, fibrin, and fibrinogen fragments 
has been studied by several investigators. The values obtained have 
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exhibited considerable variance even in the same species, but this 
could be explained on the basis of the different methods of analysis 
used in these determinations, as well as variants of fibrinogen that 
ex··t. Bovirte fibrinogen has been reported to contain 31 hexose 
residues (D-mannose and D-galactose in an average ratio of 1.1: 1.0) 
and 10 residues of sialic acid (83). Sialic acid appears to contain 
a mixture of N-acetylneuraminic acid and N-glycolylneuraminic acid 
(84). Two variants of the Y-chain of bovine fibrinogen have been 
isolated, one of which not only had a lower content of sialic acid 
resulting in lowr anodic mobility but also had a lower hexose and 
hexosamine content (85). Human fibrinogen has been reported to con-
tain a total of about 23 residues of hexosamine and six to seven resi-
dues of sialic acid (57). The carbohydrate composition for the high-
solubility fibrionogen was reported to be roughly the same as the in-
termediate-solubility fibrinogen (hexose 27, hexosamine 20, sialic 
acid 6), which means peptides released during degradation do not con-
tain carbohydrates (57,86). Several studies have reported on the dis-
tribution of the carbohydrates among the three chains (87-90). Some 
reports have shown that all the chains of human fibrinogen contain 
carbohydrates though the a(A) chain is relatively deficient (87,88); 
furthmore, Mills and Triantaphyllopo1s (88) suggested that the three 
fibrinogen chain pairs are not symmetrically paired with respect to 
the sites of carbohydrate attachment. This is due to the fact that 
the carbohydrate moieties of bovine fibrinogen are about equally dis-
tributed bet\~een asparagine-lysine and asparagine-arginine sequences. 
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Others have suggested that all carbohydrates in human fibrino-
gen are attached to the B(8)- and Y-chains while the a(A) chains do 
not contain carbohydrates (89-91). All carbohydrates of the 6(8) 
chain are found on the 0 fragment while all carbohydrates of the y 
chain are localized on the E fragment (90). The site of attachment 
of the carbohydrate moiety in fibrinogen has been studied by several 
investigators. All glycopeptide chains show two main types of attach-
ments (92,93). The carbohydrate chains are attached to asparagine 
which has either a lysine or arginine as the next C-terminal neighbor-
ing group. 
Attempts to clarify the primary structure of the oligosaccha-
ride chains in bovine fibrinogen have been made with some success by 
Mester and his coworkers (93,94). The structures of the oligosaccha-
rides in three glycopeptides A, 8, and C isolated from a "pronase" 
digested mixture of fibrinogen were established by means of oxidation 
with sodium periodate and subsequent reduction with sodium borohydride, 
followed by methylation with methyl iodide and partial hydrolysis of 
desialized glycopeptides. The average oligosaccharide is branched 
and composed of four residues of D-glucosamine, four residues of 0-
mannose and three residues of D-galactose. In the glycopeptides 8 
and C, two of the three galactose residues are substituted by sialic 
acid. The sialic acid is in a terminal position. One sialic acid 
res i due is 1 inked through a 2 ~ 3 1 i nkage and the other a 2 -7 6 
linkage. In glycopeptide A, there is only one sialic acid residue 
and this is linked 2 ~ 3 to galactose. The galactose residues are 
linked to N-acetylglucosamine forming N-acety1lactosamine. Of the 
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four rnannose residues only two can be oxidized by periodate and these 
seem to be linked as in mannobiose (1 ~ 6). The two nonoxidizable 
residues are linked through 1 ~ 3 linkages (Figure 6). 
2.3 Gamma-globulins 
2.3.1 Structure and Conformation (95,97,98) 
Antibodies are produced by the body in response to the pre-
sence of a large variety of foreign substances (antigens). The anti-
gens are usually protein or carbohydrate in nature. Antibodies are 
members of a group of related proteins called immunoglobulins which 
are symbolized as 19. Presently, five classes of immunoglobulins are 
known and are designated as IgG (about 75%), IgA (about 17%), IgM 
(about 7%), IgD and IgE. The IgG immunoglobulins are most abundant 
and well understood. All immunoglobulin classes so far examined have 
the same fundamental structure consisting of four polypeptide chains 
linked by interchain disulfide bonds. Thus, all immunoglobulins have 
a four-chain symmetrical structure which contains two light chains and 
two heavy chains (F'igure 7). The light chains are of two types, 
kappa (K) and lambda (A), and an individual immunoglobulin molecule 
may contain either two kappa chains or two lambda chains but never one 
of each. Each chain can be divided into two halves of almost equal 
length. The N-terminal half shows considerable difference from pro-
tein to protein, and is consequently termed the variable (V) or speci-
ficity (5) region. On the other hand, the C-terminal half is virtu-
ally identical in all of the sequences and is, therefore, termed con-
stance (C) or invariant region. Each half contains a 60 amino acid 
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Figure 7. Schematic representation of an immunoglobulin molecule. 
The short thick lines represent the disulfide bonds. 
The intrachain bonds are shown closing the "disulfide 





Figure 8. Schematic representation of an IgG molecule showing 
the point of cleavage by papain and pepsin in the 
hinge region and the origin of the various fragments. 
Papain gives rise to Fab and Fe and pepsin to F(ab~)2 
and Fc~(from Ref. 95). Used by permission. 
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The heavy chains are specific to, and determine the class of 
immunoglobulins and are correspondingly designated gamma (Y), alpha 
(a), mu (w), delta (6), and epsilon (s). They range in molecular 
weight from about 50,000 for gamma chains to about 80,000 for epsilon 
chains. Mu chains have a molecular weight of about 65,000 - 70,000. 
This is considerably greater than that of gamma chains, which is due, 
in part, to their extra carbohydrate content. Each of the immuno-
globulin has a characteristic carbohydrate content which varies from 
a total of about 22 monosaccharide residues in IgG to about 82 -in 
monomeric IgM (95). The heavy chains are approximately twice the 
length of light chains. As with light chains, heavy chains contain 
a variable region which is one quarter of the total length from the 
N-terminus. The sequence of human and rabbit gamma chains in the 
hinge region is usually rich in proline residues, which is most likely 
responsible for its flexibility. Although antibody activity appears 
to be associated with the N-terminal segments of both the heavy and 
light chains (Fab fragments), many biological properties are exclu-
sively associated with the heavy chains. 
IgG can be split by controlled proteolysis with papain or 
pepsin into biologically active fragments, two Fab (fragment, antibody-
binding) and one Fc (fragment, crystallizable), or one F(ab')2 and 
two Fe" respectively (Figure 8). Fab contains the antibody activity 
of the molecule, ,tJhereas the other biological activities such as 
placental transfer and heterologous skin binding are present in Fc· 
The pepsin digestion fragment F(ab')2 contains the two antibody sites 
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(divalency) of the original protein and its monovalent piece is de-
signated as Fab, · The fragments Fab and Fab , consist of intact light 
chain linked to the N-terminal portion of the heavy chain. The N-
terminal protion of the heavy chain remaining attached to the light 
chain is known as Fd or Fd,. 
Two topographical models have been proposed for IgG immuno-
globulin. Edelman and Gally (98) considered the molecule to be a 
rigid rodlike structure with the antibody combining sites at the ex-
treme ends of the rod. Noelken, et al., however, proposed a model in 
which most of polypeptide chains are incorporated into three compact 
globular regions, corresponding to the Fab and Fc fragments, linked 
by a flexible extended portion of the heavy chain (99). Many findings 
have revealed a structure consisting of compact Fab and Fc regions 
linked by a flexible, extended portion which is a portion of heavy 
chain. This flexible molecular model has been continously extended 
in order to account for new experimental results. The overall mor-
phology of the IgG molecule is V-shaped and made up of three fragments 
representing the Fab and Fc (100). The angle between the two Fab 
fragments is apparently variable between 0 and 180 degress, indicating 
that the molecule is flexible. Each arm (Fab ) has been found to be 
o 
about 70 A long. Thus, the maximum span of the molecule is approxi-
Q 
mately 140 A (101). But in the absence of hapten, the angle has been 
estimated to be about 80° to 95°; nanesecond fluorescence polarization 
indicated that the F h arms can rotate freely through a 33° angular 
au 
o 
range. An IgG1 n~e1oma protein at 6 A resolution was found by X-Ray 
to be in the form of a T in the crystal (102). 
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Normal human 19M immunoglobulins have a molecular weight of 
900,000 as do rabbit 19M immunoglobulins. These consist of five 
monomers (IgMs ) obtained by reduction or alkylation. These monomers 
have a molecular weight of about 180,000 and appear to consist of two 
mu chains and two light chains linked by disulfide bridges similar to 
those found in 19G immunogolub1ins. The monomers are linked to each 
other by single disulfide bridges within Fc part involving a half 
cystine residue near the C-termina1 end of the mu chain. Each monomer 
is linked to two others to give a star-like structure with a central 
ring from which five arms radiate. 
The conformation of immunoglobulins in solution have been 
studied using optical rotatory dispersion (ORD) and circular dichroism 
(CD). A detailed interpretation of specific conformations has not 
been successful. The immunoglobulins and their fragments are devoid 
of a-helix, and the presence of low amounts of the S-conformation is 
feasible (103). The formation of antigen-antibody complexes increases 
the amount of a-form (104). The amount of 6-structural order in light 
chains has been found to be more in the constant region than in the 
variable half regions. The sum of the CD spectra of the isolated con-
stant and variable parts is nearly identical with the CD spectrum of 
the protein, indicating that the variable and constant segments of 
the light chain have more or less independent domains of secondary 
and tertiary structures (105,106). The ORO of IgG and IgM produces 
an appropriate combination of the spectra of their respective Fab and 
F fragments indicating that little change in conformation occurs dur-
c 
ing proteolysis (107,108). There ar'e significant differences between 
28 
CO spectra of immunoglobulin light and heavy chains. The algebraic 
sum of the subunit spectra do not yield the spectrum of parent immu-
noglobulin, indicating that unique conformational features of the in-
tact protein (109) exist. 
2.3.2 Carbohydrates of Gamma-globulins 
2.3.2.1 IgG Immunoglobulin 
The carboydrate content shows considerable differences among 
the major classes of immunoglobulins, being lowest in the IgG ;~luno­
globulins and highest in the IgM immunoglobulins (Table 1) (110). 
IgA, IgM, IgO and IgE contain considerably more carbohydrates than IgG. 
IgA and IgO have similar carbohydrate contents and are the only immu-
noglobulin classes in humans so far found to contain N-acetyl galacto-
samine. 
The nature and site of attachment of the carbohydrate units 
of the IgG immunoglobulins have been studied extensively after isola-
tion of glycopeptides obtained from proteolytic digests of normal and 
myeloma proteins (Figure 9). Both human and rabbit IgG immunoglobu-
lins uniformly contain an asparagine-linked carbohydrate unit on each 
of the two heavy chains. These units are located in the Fc fragment, 
part of the constant portion of these peptide chains. T~e exact site 
of attachment has been determined for a myeloma immunoglobulin IgG 
through the complete sequence analysis of the protein at the 297 posi-
tion (111). Some IgG myeloma immunoglobulins have been found to con-
tain additional asparagine-linked carbohydrate units attached to the 
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Figure 9. Schematic portrayal of the distribution of carbohydrate 
units (C) on IgG. Cl' present in both rabbit and human 
protein; C2' attached to hinge region of one heavy chain 
in most rabbit IgG; C3~ found in a small percentage of 
both rabbit and human IgG; C4' reported to be present in 
a small percentage of human Tight chains; L = light chains, 
H = heavy chains; jagged line, variable portion; straight 
line, constant portion (from Ref. 110 , P. 404, by courtesy 
of Academic Press, Inc.). 
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pooled rabbit IgG immunoglobulins, about 15 percent of the heavy 
chains contain such additional asparagine-linked carbohydrate units 
(113). These carbohydrate units from the Fd portion of the rabbit 
heavy chains contain glucosamine, mannose, and galactose like those 
attached to the Fc fragment, but do not contain sialic acid or fucose 
as sugar constituents. It has further been shown that about 40 per-
cent of the heavy chains of pooled rabbit IgG immunoglobulins contain 
a threonine-linked carbohydrate unit which is located in a proline-
rich amino acid sequence in the hinge region of the molecule (114). 
But this unit, which contains all of the N-acetyl galactosamine of 
the molecule, is asymmetrically present on only one heavy chain. The 
galactosamine has not been detected in human normal or myeloma IgG 
immunoglobulins indicating that the occurrence of the threonine-
linked unit is species dependent. 
Investigations of the carbohydrate structure of the light 
chains of the IgG immunoglobulins have been conducted on individual 
Ig myeloma and Bence-Jones proteins. Bence-Jones proteins are ob-
tained from the urine of patients with multiple myeloma and are identi-
cal in amino acid sequence to the light chains of the corresponding 
myeloma globulins. It was shown that the light chains of some IgG 
globulins contain asparagine-linked carbohydrate units which appear 
always to be attached in the variable portion of the chain (112,115). 
Such units have been found in both kappa (K) and lambda (~) chains 
and are attached to asparagine residues in the characteristic Asn -~ 
X ~ Ser (Thr) sequence. The carbohydrate units of the light chains, 
like those attached to the F portion of the heavy chains, contain c . 
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galactose, mannose, glucosamine, fucose, and sialic acid as their 
saccharide constituents. The carbohydrate composition of the units 
on the Bence-Jones proteins is simlar to that of the light chains 
isolated from the corresponding myeloma proteins, except for a higher 
sialic acid content (112). 
The structure of the oligosaccharide units linked to the Fc 
portion of each of the heavy chains of human IgG immunoglobulins have 
been studied in detail by several investigators. ~1ost recently, Korn-
feld, et al., (116) investigated the carbohydrate structures of glyco-
peptides isolated from seven IgG myeloma immunoglobulins and IgG im-
munglobulin of one normal individual. All the glycopeptides are 
branched oligosaccharides containing two nonreducing termini with the 
sequence: 
Sialic acid ~ D-Galactose 
~ D-Mannose. 
N-Acetyl-D-glucosamine 
The number of sialic acid, fucose, and galactose residues is variable, 
which leads to microheterogeneity of the outer branches of carbohy-
drates. Thus, the two outer branch oligosaccharide chains are present 
in varying degrees of completion, often not having a full complement 
of sialic acid and galactose residues. The presence of carbohydrate 
units with the incomplete outer chains could result from a deficient 
biosynthetic mechanism. When a sialic acid residue is present, as 
the terminus, it is linked 0.2,6 to the galactose residue. The two 
kinds of outer branches (incomplete or complete) are connected to a 
mannose residue in the core, which contains either two or three 
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N-acetyl glucosamine (GlcNAc). The sequence of sugars in the core 
varies from one glycopeptide to another, being either: 
Man GlcNAc ~ GlcNAc ~ Asn, 
~1an --) [Gl cNAc ~ ]Gl cNAc Asn, or 
Man ~ GlcNAc -4- [GlcNAc ~ ]GlcNAc ~ Asn. 
Three such structural variants are depicted in Figure 10. One man-
nose is found as a branch point in the glycopeptides of all myeloma 
immunoglobulins examined. It is linked either to the outer or inner 
component of a di-N-acetyl glucosamine, which, in turn, ;s attached to 
asparagine. Such a di-N-acetyl glucosamine has been identified from 
the core of a glycopeptide in which the sequence: 
Mannose ~ N-Acetyl gl ucosami ne ~ N-Acetyl gl ucosami ne 
~ Asparagine occurs. 
The core portion of the carbohydrate units of some IgG myeloma immuno-
globulins contain a third N-acetyl glucoasamine residue the precise 
position and linkage of which is not yet known. Variation in the 
number and arrangement of the N-Acetyl glucoasamine residues of the 
core portions is found only in proteins from different individuals. 
2.3.2.2 IgA immunoglobulin(117) 
All carbohydrates of the IgA immunoglobulins have been found 
on the heavy chains in the form of three complex and one single 
asparagine-linked and two serine (or threonine)-linked units per 
molecule (Figure 11). The odd number of asparagine-linked units 


























































































































































































































































































Man~ (2/4) Man----. (2/4) Man ----.( 3/4} GlcNAc ~ Asp 
(2/4) (412) (4/2) (6/4/3) 
















Man---+ (3) Man--.,.. (3)Man--+(3)Man--+ (3/4)GlcNAc-... 
(3/4) Glc NAc ---. (3/4)Glc NAc --+' .~sp 
NANA-io (3) Ga 1---+ (6)GaINAc -~t. (3/4) Gal NAc---.,. 
Fi gure 11. 
(2/4)Gal---+ (2/4) Go 1-.-. . (3/4) Gal NAc ---. .Ser 
The carbohydrate units of IgA immunoglobulin; (A) complex 
units, (B) simple asparagine linked unit, (C) serine 
for threonine) linked unit. , 
two heavy chains. The three complex asparagine-linked units have 
been shown to have the sequence: 
Sialic acid ~ D-Galactose ---~ N-Acetyl glucosamine 
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attached to an internal portion of three mannose residues and one 
additional i~-Acetyl glucosamine. The location of the single fucose 
has not yet been clearly determined. All the sialic acids are at the 
terminus and linked to D-ga1actose at C-2, C-4, or C-6. The simple 
asparagine-linked unit contains only D-mannose and N-Acetyl glucosa-
mine in the ratio of four to three. Mannose appears to be terminal 
and present in a sequence of at least three D-mannose residues. The 
carbohydrates of the serine (threonine)-linked units are O-glycosidi-
cally linked to the hydroxy amino acid, serine (threonine). Sialic 
acid is linked to the C-3 hydroxyl group of the D-galactose residue 
as a terminus. Each of these three types of oligosaccharide chains 
occurs in various stages of completion to give peripheral heterogeneity 
or micra-heterogeneity. 
2.3.2.3 IgM immunoglobulins 
19M immunoglobulins contain a large amount of carbohydrate 
which is distributed among five oligosaccharide chains on each mu 
he a v y c h a ins (11 8 , 1 20) . Inc 0 n t r as t , the rna j 0 r i ty 0 fIg G i rnmu n 0 9 lob u-
lins contain only a single glycopeptide per heavy chain. Each 19M 
monomer- has a tota1 of 10 asperagine-linked carbohydrate units, of 
which six are of the complex type that contain sialic acid, galactose, 
mannose, N-Acetylglucoasamine, and fucose, and four are of the simple 
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form containing only mannose and N-acetyl glucosamine residues (119, 
120). The oligosaccharide chains are attached at five sites in the 
constant sequence region of the mu heavy chain (Figure 12). One com-
p1ex uni tis located in the Fd fragment at approximately position 
170, another in the hinge region near position 230, and the third in 
the Fc region. Both simple units are attached in the F c region of 
the heavy chain. One is 1 oca 1 i zed on the fourtheenth residue from 
the C-terminus of the chain. 
Hickman, al., (120) isolated five different glycopeptides 
from 19M immunoglobulins and investigated the structure of the oligo-
saccharide portion of four of the glycopeptides. The complex carbo-
hydrate units demonstrate extensive micro-heterogeneity with varying 
degrees of completion of the terminus in the sequence: 
Sialic acid ~ Galactose ~ N-Acetyl glucosamine 
Mannose. 
This sequence appears to conform to a structural pattern similar to 
that of the carbohydrate units of human IgG iwmunog10bulins (Figure 
13). The sialic acid is linked a2 ~ 6 to the galactose residue 
in all cases and the N-acetyl glucosamine residues in the outer 
branches are linked 61 2 to the underlying mannose residues. 
The simple carbohydrate units are also branched and consist of a 
variable number of mannose residues attached to two internally located 
N-acetyl gl ucosami ne resi dues. 
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Figure 12. Schematic diagram of the polypeptide structure of a 
monomeric unit of the human IgM macroglobulin Qu. 
The zigzag lines are variable regions, the straight 
lines are constant regions. Tryptic cleavage occurs 
in the hinge region just before the mu-mu interchain 
disulfide bridge. The oligosaccharides designated 
C1-C5 are located on each mu chain. Cl is located 
at about 170 position, C2 in the hinge region at 
about 230, and C5 at the COOH terminus. C3 and C4 
are both in the Fc~ section. Complex oligosaccharides 
(C1, C2, C3) are indicated by solid circles and simple 
oligosaccharides (C4 and C5) by stippled circles 
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Figure 13. The structures of the ISM glycopeptides(from Ref. 120l 
Used by permission. 
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3. PROPOSED MECHANISM OF PLATELET AGGREGATION 
AND ADHESION 
3.1 Enzyme Reaction of Two Substrates (121,122) 
Enzymes catalyzing bisubstrate reactions include the large 
class of transferases which catalyze the transfer of a specific func-
tional group from one of the substrates to the other. The kinetic 
analysis of two substrate reactions, symbolyzed by the equation: 
E 
A + B P + Q 
is more complicated than for one substrate reaction because they may 
have several enzyme-substrate complexes, such as the binary complexes 
EA, EB, EP, and EQ, and the ternary complexes EAB, EPQ, E.~Q, and EPB. 
r·1ost two-substrate reactions can be classified in one of two ways, 
single-displacement reactions or double-displacement reactions. This 
generally can be distinguished by kinetic analyses. 
In the single-displacement reactions, both substrates A and B 
must be present on the enzyme active site simultaneously to give a 
ternary complex EAB in order for the reaction to proceed. Sing1e-
displacement reactions occur in two forms: random and ordered, which 
differ in the sequence in which the two substrates bind to the enzymes. 
In random bisubstrate reactions, either substrate may bind to 
the enzyme first, indicating that the ternary complex, EAS can be 
found equally well in two different ways: 
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A + B ---4) EA 
.... 




E + B I( --~';) EB 
EB + A EAB 
In ordered single-displacement reactions, there is a compul-
sary sequence of reaction, so that one specific substrate, the leading 
substrate, must be found first, before the second, or following, sub-
strate can be bound, as shown in the reactions: 
E + A EA 
EA + B EAS 
where A is the leading substrate. Under certain conditions the ternary 
complex, EAB, is present in vanishingly low concentrations. Under 
these conditions, only EA and the second substrate, B, exist, without 
apparently forming an EAB complex. 
In the double-displacement reactions, one substrate must be 
bound and one product released before the entry of the second product. 
In such reactions, the first substrate reacts with the enzyme to yield 
a chemically modified form of the latter, usually by transfer of a 
functional group. In the second step, this functional group is tran-
sfered from the enzyme to the second group. These two-step bisubstrate 
reactions are descriptively called ping pong reactions. 
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3.2 Proposed Mechanism 
A number of platelet membrane-associated enzymes have been 
isolated (48,49,122,124). Of particular interest have been the 
glycoprotein galactosy1 transferase and the glycoprotein-N-
acetylneuraminic acid transferase. Both are located in the platelet 
membrane and require divalent cations for their activity. These gly-
cosyl transferases may be important not only for the synthesis of gly-
coproteins, but also for the glycoprotein-platelet association, 
platelet aggregation and release induced by the glycoproteins. 
In the synthesis of glycoprotein oligosaccharide chains, mono-
saccharide units are transfered from their nucleotide derivatives to 
appropriate acceptors, the glycoproteins. Each of these transfer 
reactions is catalyzed by a different glycosyltransferases for a parti-
cular acceptor molecule. 
Glycoprotein-galactosyltransferse catalyzes the transfer of 
galactose from UDP-galactose to an appropriate acceptor which has 
terminal N-acetyl glucosamine or glucose. 
UDp-galactose + acceptor (N-acetyl glucosamine) 
------Jl') gal actose-acceptor + UDP (a) 
Glycoprotein-N-acetylneuraminic acid (sial ic acid) transferase 
catalyzes the transfer of sialic acid from CMP-sialic acid to receptor 
sites in glycoproteins. The receptor sites are terminal galactose or 
N-acetyl galactosamine residues of the ol;gosacchar~ide chains of gly-
coproteins. 
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CMP-sialic acid + acceptor (galactose) 
,---.."..) s i ali c a c i d -a c ce p t r + cr~ P ( b ) 
The sialic acid transfer reaction is inhibited by D-glucosamine, 
aspirin and DUP (48), but the galactose transfer reaction is inhibited 
only by UDP (123). 
The terminal trisaccharide unit of serum-type glycoproteins 
is formed by a stepwise addition of the monosaccharides N-acetyl 
glucosamine, galactose, and sialic acid (Figure 14) as shown in the 
above reactions (a) and (b). The transferase enzymes are capable of 
complexing, along with the proper sugar nucleotide and divalent cation, 
with a glycoprotein containing appropriate acceptor sites. The forma-
tion of a complex between enzymes and substrates in the reactions (a) 
and (b) can be applied to platelet-glycoprotein interaction, platelet 
aggregation, and platelet adhesion onto a surface (125). 
Gamma-globulin and fibrinogen are major blood glycoproteins 
whose oligcsaccharide chains have the same structural pattern with the 
following scheme: 
Peptide 
ASP ASP : Asparagine 
i 
GNAc MAN ~ Monnose 
l' SA : Sialic acid MAN MAN MAN 
t t l' GNAc: N Acetylglucosamine GNAc GNAc GNAc 
t t 
Gal Gal Gal ~ Galactose 
t 
SA 













__ .It * ~ 
G~~~~C \ ~~P ll~~~~ I 
G 01---- --[ UDP- Gall 
1 
NANA4- ---I CMP-NANAj 
Figure 14. Synthesis of the terminal trisaccharide units in serum 
glycoproteins. The monosaccharids, N-acetyl glucosamine 
(GlcNAc), galactose (Gal), and N-acetylneuraminic acid 
(NANA), are transfered to the indicated acceptors from 
the corresponding sugar nucleotides by specific gly-
cosyltransferases (from Ref. 47). 
45 
Each of the oligosaccharide chains is completed vJith varying degrees 
of completion and are often terminated with galactose or even N-
acetyl glucosamine. Such a heterogeneity has been attributed to the 
failure of optimal conditions for a specific multiple glycosyltrans-
ferase system (47). The incomplete oligosaccharide chains are recep-
tor sites for enzyme-substrate complexes. Gammaglobulin and fibrino-
gen containing these appropriate receptor sites can form complexes, 
binary or ternary, with the platelet membrane-associated enzymes. 
Borrowing the concepts from the reactions schemed in (a) and 
(b), working models for platelet-glycoprotein interactions can be 
provided: 
Platelet + Glycoprotein ,,~---) [Platelet-Glycoprotein] (c) 
In this reaction, platelets interact with glycoproteins, mainly 
fibrinogen and gammaglobulins. The equilibrium is directed towards 
the left side of the reaction. This can be considered the case for 
normal platelets under physiological condition. 
Platelet + Glycoproteins ~ > [Platelet-Glycoprotien] (d) 
However, for the reaction (d), the equilibrium in (c) is modified by 
excess binding of glycoprotein with platelets due to the favorable 
forward reaction. The changes of platelet cell surfaces either by 
drugs or abnormal physiological conditions, may cause the shift of 
equilibrium resulting in platelet aggregation. Excess glycoprotein 
on cells may become bridges and/or induce platelet release causing 
aggregation. 
The last scheme is platelet adhesion to surfaces: 
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Platelet + Adsorbed glycoprotein 
--- [Pl ate 1 et-Adsorbed protei nJ (e) 
This reaction is assumed to be an irreversible process in which plate-
lets adhere to polymer surfaces through the layer of adsorbed proteins 
as shown in Figure 15. Vihen blood comes in contact with a polymer 
surface, plasma proteins adsorb the surface and platelets then inter-
act with the proteinated surfaces. Glycosyltransferase, galactosyltrans-
ferase and sialytransferase in the platelet membrane may form a com-
plex with a nucleotide monophosphate-monosaccharide such as UDP-
galactose and CMP-sialic acid and with the glycoprotein acceptors ad-
sorbed to the polymer surfaces. Thrombogenic surfaces tend to adsorb 
glycoproteins, fibrinogen and gammag1obulins. These adsorbed glyco-
proteins induce more platelet adhesion. When the degree of incomplete-
ness is increased by removing sialic acid or both sialic acid and 
galactose, more platelets adhere to the fibrinogen and gamma globulin 
coating (which is either desialized or has both sialic acid and galac-
tose removed) than to the same coating when untreated. 
The mechanism proposed for platelet adhesion on a foreign sur-
face is very similar to that for the role of collagen-glucosyltransferase 
in adhesion of platelets to collagen (50). An enzyme-substrate com-
plex may be sufficiently strong enough to account for the firm adhesion 
of platelets onto the adsorbed proteins, Such a strong complex can 
be envisioned in the aggregation of cells, including platelets by 
lectins and in affinity chromatography where there are several examples 
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The proposed mechanism of platelet adhesion 
onto a polymer surface. 
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and carbohydrates. For example, N-acetyl galactosaminyltransferase 
binds to agarose (125) and glucosamine (127). Ashwell and coworkers 
(128,129) have identified galactosyl residues in plasma glycoproteins 
as being the determinants for their binding to the plasma membrane of 
liver cells and have shown that the solubilized protein of the mem-
brane will bind to insolubilized glycoproteins having terminal galac-
tosyl residues. As shown above, noncovalent binding could be suffi-
ciently strong enough to effect the binding of platelets to adsorbed 
protein. Whereas a covalent bond between the glycosyltransferases 
and glycoproteins may be involved, as in the binding of serum inhibi-
tors to serum proteins (130) or in covalent catalysis (131), although 
this usually requires a ping-pong mechansim .. 
The objectives of this dissertation is toward indirect verifi-
cation of the proposed mechanism using platelets and glycoproteins. 
4. PLATELET AGGREGATION AND RELEASE 
4.1 Aggregation and Release 
Mammalian platelets are nonnucleated elements derived from 
the megakaryocyte in the bone marrow. In circulating blood, plate-
lets are disk-shaped. They have an outer membrane which encloses 
cytoplasmic constituents such as storage granules, lysosomes, mito-
chondria, glycogen, a vascular component which may be the remnants 
of the Golgi apparatus or endoplasmic reticulum, microfilaments, and 
microtubules. platelet metabolism is similar to that of nucleated 
cells and includes a capacity for protein and fatty acid synthesis 
(1 32) . 
Platelets are involved in the response of the organism to 
injury of the endothelial lining of blood vessels, in its response to 
the introduction of foreign materials and chemicals into the blood 
stream, and in its reaction to many metabolic products that enter the 
blood. The initial response of the platelets to various stimuli most 
generally begins with a shape change of the platelets, that is, a mor-
phological change from their normal disk shape to a more isotropic but 
irregular form which is basically spherical with pseudopods. This 
initial chan~e is not dependent on the presence of calcium nor on 
stirring but the subsequent aggregation reaction is (133). This pro-
cess of platelets leads to an increased adhesion of the pletelets to 
each other and to foreign surfaces, the release of platelet material 
into the ambient fluid, and the formation of filamentous processes. 
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Adenosine diphosphate (ADP) has been established as a key com-
pound causing aggregation. Several others such as thrombin and colla-
gen have also been shown to induce platelet aggregation followed by 
the release of platelet constituents, including adenosine nuc1eotides. 
Several hypotheses have been proposed to explain ADP-induced platelet 
aggregation: calcium bridge formation between ADP attached to plate-
lets (134), conversion of ADP to AMP (135), inhibition of ecto-ATPase 
by ADP (136,137), or inhibition by ADP of contractile activity of a 
contractile protein (thrombosthenin) with ATPase activity (138). 
Thombosthenin is closely associated with the platelet membrane, which 
is indicated by: the presence of filamentous structures that form 
bridges between the adhered platelets (139), antithrombosthenin inhi-
bition of ATPase activity of the platelet surface (136), and anti-
thrombosthenin-induced platelet aggregation (140). 
Platelet stimulation is linked to an increase in the cyto-
plasmic calcium level. Calcium can be mobilized from storage organel-
les inside the platelet, as well as by influx through the plasma mem-
brane, which acquires an increased calcium ion permeability upon sti-
mulation (141). Experiments with ionophores, capable of transporting 
calcium ions across membranes, have also shown release to be calcium 
ion dependent. The release reaction constitutes a rapid discharge of 
the contents of dense bodies and a-granules from platelets to the 
extracellular environment. The specific release of granular materials 
from, platelets is termed the II p1atelet release reaction.1: The re-
lease reaction from the dense granules and the a-granules are governed 
by different mechanisms referred to as release I and release II, 
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respectively. Serotonin and adenine nucleotides are released more 
rapidly from dense granules than the substances such as acid hydro-
lases from the a-granules. Mustard and Packham (132) showed a non-
specific release reaction induced by several different release indu-
cers. Such a phenomenon referred to as lysis of the platelet probably 
occurs as a result of the entire process of the release reaction caus-
ing a generalized release of platelet constituents. These various 
release inducers function at the platelet membrane surface. Numerous 
membrane structures have been proposed as the targets of these indu-
cers, including fibrinogen, betaglobulin, alphareceptors, membrane 
ATPase, etc. (142). 
The release reaction is an active process which requires ATP. 
Energy production in the form of ATP is required for the platelet re-
lease reaction (143). Several hypotheses have been proposed on the 
process of ATP consumption in the release reaction (144,145,138). The 
release stimulus acts on the membrane to make bound calcium available 
for thrombosthenin. This creates (in the presence of ATP) a contrac-
tion wave resulting in a relative movement between the storage granules 
and the plasma membrane. Thus, the storage granules can be released 
by fusing with membrane at the contact point or by being centralized 
by a membrane invagination (146). 
4.2 The Involvement of Plasma Proteins in Platelet 
Aggregation and Release 
It has been recognized that plasma factors play an important 
role in platelet aggregation and also in platelet adhesion onto foreign 
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surfaces. Patients suffering from von Wi1lebrand 1 s disease exhibit 
prolonged bleeding times and decreased platelet adhesiveness. This 
is due to a decreased activity of a plasma factor called anti-
Wi11ebrand factor. Injections of human plasma fraction 1-0 correct 
the prolonged bleeding time in this disease (147,148). It is known 
that other heat labile plasma factors are required for the full ef-
fect of ADP as an aggregating agent. Born and Cross (149) have shown 
that washed pig platelets failed to aggregate in buffered saline 
solution containing calcium ions. However, upon the addition of PPP, 
ADP-induced aggregation increases with the logarithm of the PPP con-
centration. The active substance in plasma is: heat labile, not 
adsorbed by alumina, and present in the euglobulin fraction of plasma 
and in fractions of factor VIII. A similar cofactor has also been 
found necessary for ADP-induced aggregation of washed platelets pre-
pared from a number of mammalian species (150). The active plasma 
substance has been identified as fibrinogen. The addition of fibrino-
gen to washed platelets resuspended in buffered saline solution con-
taining calcium ions causes ADP-induced platelet aggregation (36,143, 
151). This aggregation can be optimized at a final concentration of 
about 0.2 mg/ml and levels off at higher concentrations of fibrinogen 
(153). The deficiency of fibrinogen characterizes congential afibrino-
genemia. The bleeding time has been found to be prolonged in such 
patients. Afibrinogenemic platelets, although initially indistinguish-
able from normal ones t behave in a different fashion. These plate-
lets are not able to aggregate upon addition of ADP, adhere to glass 
or display the typical spreading phenomenon (154,155). Addition of 
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fibrinogen normalizes the afibrinogenemic platelets. Larger amounts 
of ADP are required with afibrinogenemic platelets without adding 
fibrinogen cofactor than with platelets from normal plasma (155). 
Fibrinogen adsorbed on the platelet surface may be involved in ADP-
induced platelet aggregation. Plasma fibrinogen labelled with 1131 
or 1125 is adsorbed onto washed platelets and disappears during sub-
sequent washings (34,157,158). In addition to the exchangeable sur-
face fibrinogen, platelets contain intracellular fibrinogen associated 
with granules or mitochondria, or both (157,159), but such an exchange 
reaction does not occur between the intra-platelet and plasma fibrino-
gen. Though intra-platelet fibrinogen is most probably not involved 
in aggregation induced by low concentrations of ADP, intra-platelet 
constituents may be released under conditions such as high ADP con-
centrations. Released intra-platelet constituents may take part in 
platelet aggregation since platelets from patients with afibrinogenemia 
contain fibrinogen in the granular fraction (140). Apart from the 
cofactor effect of homologous fibrinogen on ADP-induced adhesion and 
aggregation, it has been shown that both normal human platelets and 
thrombosthenic platelets are directly aggregated using purified human 
(34) and bovine (160,161) plasma fibrinogen and bovine platelet fi-
brinogen (162). It has been found that thombin and trypsin release 
intracellular fibrinogen (144). External fibrinogen is not required 
for thrombin-, adrenalin-, and collagen-induced aggregation of washed 
platelets in heat inactivated plasma (152). This indicates that re-
leased intracellular platelet fibrinogen may ~ct as a cofactor in the 
aggregat~on reaction. 
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The presence of fibrinogen, gamma-M-globulin, and gamma-G-
globulin on or in normal platelets has been de~onstrated (163,164), 
but thrombosthenic platelets are unable to adsorb normal amounts of 
plasma proteins of high molecular weight. The platelets fail to 
aggregate when exposed to ADP, norepinephrine, or serotonin, and also 
show defective adherence that such platelet-bound gamma-M-globulin 
as well as fibrinogen may be involved in ADP-induced aggregation of 
normal human platelets (165). Immunoglobulin G prepared from a pa-
tient with a severe chronic thrombocytopenic purpura makes washed 
platelets susceptable to aggregation by ADP and produces platelet 
clumping in platelet-rich plasma (166). The platelet clumping by the 
immunoglobulin is mediated by the release of platelet ADP. This phe-
nomenon may be caused by the immunoglobulin attachment to the plate-
let surface and the immunoglobulin subsequently produces the protein 
environment which can be necessary for aggregation by ADP. As alterna-
tive explanation, antigen-antibody reaction on the platelet membrane 
may produce such a modification of the latter followed by the aggrega-
ti on of ADP. 
Coating the surfaces of extracorporeal shunts with gammaglobu-
lin or fibrinogen enhances thrombus formation from flowing blood in 
rabbits (167). A drastic effect has been found when the surfaces of 
the shunt are coated with gamm~-globulin. Albumin-coated surfaces, 
on the other hand, have no enhancing effect. Acetylsalicylic acid 
given intravenously has reduced thrombus formation en the gamma-
globulin-coated surfaces. Platelets interact with gamma-globulin ad-
sorbed surfaces or particles, or in the presence of antigens with 
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which gamma-globulin can form immune complexes. Polystyrene particles 
(29,168-171) or glass surfaces (30,167,171) coated with plasma or 
gamma-globulin cause the release of constituents, platelet serotonin 
and nucleotides, including ADP. In certain species, like rabbit, 
gamma-globulin-coated surfaces do require added components up to C3 
or perhaps C5 (blood glycoproteins) in order to cause release of 
histamine from washed platelets (172). Antigen-antibody complexes can 
also induce release and aggregation from washed pig and human plate-
lets without any complement (172), but washed platelets from rabbit 
require added complement (173). Antigen-antibody complexes as well 
as gamma-globulin coated surfaces also cause the release from 
washed human or pig platelets of a factor or factors, in addition 
to serotonin and histamine, which increases vessel permeability and 
causes contraction of smooth muscle (174). 
The release reactions induced by gamma-g1obulin-coated sur-
faces or antigen-antibody complexes are dependent upon metabolic 
energy, and require divalent cation (172). The addition of antigen-
antibody complexes to suspensions of washed pig or human platelets 
produces morphological changes similar to those caused by thrombin 
and collagen. 
5. CIRCULAR DICHROISr~: THEORY AND ITS APPLICATIOiJ TO 
ANALYSIS OF PROTEIN CONFORMATION 
5.1 Theory (175,176) 
If the two cirular1y polarized components of plane polarized 
light pass a nonoptica1ly active medium, they travel at the same velo-
city and the line of polarization of the emergent plane polarized 
light is the same as that of the incident light. But if the plane 
polarized light travels through an optically active medium, the cir-
cularly polarized components travel at different speeds through the 
medium. The difference in refractive index for the two components as 
the result of the different speeds is referred to as circular bire-
fringence which can be expressed as optical rotation, a. The extent 
of angular rotation is expressed as the specific rotation, raJ, or 
molecular rotation, [¢J: 
'y.. ( -1 -1 ) raJ = t.e \degree dm gm cc 
where c is the concentration in grams per cubic centimeter of solution, 
1 is the path length in decimeters, and ~ is expressed in degrees. 
[~] = ~1 ? - 1 [a] 100 (degrees cm- mole x 10) 
where M is the molecular weight. 
The two curcularly polarized components are also absorbed to 
different extents and the difference in absorption is referred to 
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as circular dichroism. The difference of absorption in the two com-
ponents gives rise to an elliptically polarized light. The ellipti-
city, the angle whose tangent is the ratio of the minor and the major 
axis of the ellipse, is a measure of circular dichroism. The extent 
of ellipticity is expressed as the specific ellipticity, 8, or molar 
ellipticity, [eJ. 
e (degrees) = 8~ t . c -1 -1 (degrees. dm . gm m1 ) 
where c is grams per milliliter, t is the pathlength in decimeters, 
ande~ is the experimentally measured (degrees) ellipticity. 
[e] A • M 2 -1 -1 = ~lOO ~ ~s (3300)(degree.cm . mole x 10 ) 
where M is the molecular weight, and ~s(or r) is the differential 
dichroic absorption. Average residue molecular weight is usually used 
in proteins whose molecular weight is not clearly determined. 
5.2 Application of Circular Dichroism to An 
Estimation of Protein Conformation 
Circular dichroism is currently recognized as one of the most 
useful methods for studying the conformations and conformational changes 
of globular proteins in solution. The secondary structures of globu-
lar proteins contribute to the circular dichroism (CD) in the far 
ultraviolet; much work has been carried out to unravel the structural 
information in CD. But circular dichroism is a poor structural tool 
compared to X-ray diffraction which determines protein structure ex-
actly. However, current CD methods can give useful estimates of the 
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helix, a-sheet and unordered structure in a protein in the absence of 
X-ray diffraction data. Several attempts have been made to interpret 
circular dichroism spectra of globular proteins in the region of pep-
tide absorption in terms of the contributions of the secondary struc-
ture in the proteins. To make structural interpretations from protein 
CD spectra, it has been assumed that the CD contributions of the 
secondary structures are due to helix, a-sheet and unordered struc-
ture defined by their model spectra. The protein CD spectra is a 
result of linear superposition of the contributions from three con-
formational components of the proteins. Basis spectra for the linear 
model have been chosen or calculated empirically. The spectra of 
synthetic poly a-amino acids in a-helical, antiparallel a-pleated 
sheet and random conformations have been used as basis spectra (177, 
178). Alternatively, basis spectra for helical, 3-sheet and unordered 
structure have been calculated from the CD spectra of reference protein 
whose structural composition is known from X-ray diffraction studies 
(179-181). The first spectra to be utilized to form a three component 
basis for protein CD spectra were those of the synthetic homopolypep-
tide, poly-L-lysine in a-helical, B-sheet and random coil conformation, 
respectively. Both the S-sheet form and random coil of poly-L-lysine 
have a very low ellipticity equal to approximate"iy -4,000 deg.cm/dmole 
at 208 nm. To a first approximation (177) the percent a helix can be 
calculated from: 
~'~ahelix = 
[xJ 208 - 4,000 
33,000 _ 4,000 x 100 
where [xJ 208 is the mean residue ellipticity at 208 nm of a protein 
whose structural composition is unknown. The estimation can be more 
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ref; ned or improved by the fo 11 ow; ng approach. ~\Ji th ali near three-
component model, the CD of a protein at any wavelength, in the far 
ultraviolet can be expressed as: 
( 1 ) 
where d. is the CD, expressed as mean residue ellipticity of the pro-
,\ 
tein; the X\H' X\S and X~R are the mean residue ellipticities for pure 
helix (H), S-sheet and unordered structure (R), respectively; the fls 
can be considered as the distributive coefficients of the XAH' X~B and 
XXR' or as the fractions of helix, s-sheet and unordered structure in 
the protein ltJith sumequal to t~nity. The fls can be found by writing 
equation (l) at three wave lengths and solving the three simultaneous 
equations obtained. The computations are simplified if the three wave-
lengths are chosen to be isodichroic points (crossing point of two 
sepctra) of the spectra for pure helix, s-sheet and unordered structure 
of poly-L-lysine (178). The a-helical and S-structural dichroic spec-
tra for poly-L-lysine exhibit an isodichroic point, ~aS' at 198 m~ 
max 2 
with a maxium ellipticity [x] ~~B' of + 25,600 ~ 1200 deg. cmldeciorno1e; 
~ max 
for' the set of Ct-d i sordered fo rms, \R is at 204 mp, a nd [X] AaR is 
-20,400 ~ 1400 deg.cmjdecimole; for the B-random set, the ASR is at 
208 n1fl with [X] ~ax of -6,100.! 300 deg.cm~decimole. The ellipticity 
f3R 
at each of these isodichroic points is independent of the relative 
portions of tne two conformations. Therefore, the observed ellipti-
cites for the proteins and the polypeptides at the three wavelengths 
corresponding to the three isodichroic points, and arising from only 
the three conformational reference forms, can be expressed as: 
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obs max a [d] '\ = (fp + fR) [X] ~SR + f [X]·A. SR (2) I\SR a 
obs max S 
Cd] ~a.R = (fa + f R) [X] \ + fS [X]AaR (3) A.o:.R 
obs max 
[x]R [d] \:tR = (fa + fS) [X] A S + fR (4) 0:. }, S 
Ci. 
\vh i ch simplify to: 
obs max a max 
f = ( [d] ASR [x] ASR)/([X]ASR [x] ASR ) (5 ) a 
obs max S max 
• = ([d] [x] ~ )/([x],\ - [x] ) (6) IS ~ "\ 
ctR I ctR aR '\::tR 
obs max R max 
fR = ([d] ~'aS - [x] A~B)/([x]'\aS - [X] A (7) as 
if fa + fS + fR = 1, where fa' fS' and fR are fr~ctions ~f the thre~ 
reference conformations in the molecule, and [X]\~R' [X]A Rand [X]A Q 
r-' a. a...., 
are the ellipticities of the reference a-helical, S-form and random 
coil models at the three isodichroic points. The values are -32,000 
.., 
~ 1500, + 9,800 ~ 500 and -35,400 ~ 300 deg.c~/decimole of amino acid 
residues, respectively. Equations 5-7 permit single-step evaluation 
of thewactiona1 contribution of each of the three reference forms 
from the three observed CD measurments, [d]obs, each at the wavelength 
corresponding to one of the three isodichroic points. ihis procedure 
was used in this thesis for the estimation of the proportions of 
a-helical, 8-structural and disordered conformational organizations in 
proteins. Solutions for the fls at three wavelengths can be 
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wavelength-dependent because of the approximate nature of the three-
component model and the model spectra for the secondary structures. 
It is preferable to determine the f's by fitting at several wavelengths 
in the far ultraviolet. For a seris of "m" "/avelengths the three com-
ponent models can be expressed by a matrix equation which can be solved 
by a least squares method which minimizes the sum of the squares of 
the residuals between the protein spectrum and the fitted spectrum 
made by fractional summation of three model spectra (177,181). How-
ever, the reference spectra obtained from the synthetic homopo1ypep-
tide, poly-L-1ysine, have proved to be unsatisfactory in actual prac-
tice with many proteins of known structural composition. To overcome 
the objections to the use of homopolypeptide spectra as reference 
spectra, the use of basis spectra derived from the CD spectra of a set 
of three or more proteins of known structural composition has been 
proposed (179,180). The mean residue ellipticities (for a given wave 
length) will produce a basis spectra of the a-helix, B-structure, and 
other remaining structures that are determined from reference proteins 
whose structural compositions are known. The intrinsic residue ellip-
ticities of the three structural modes made at a number of wavelengths 
can generate the CD spectra of the three structural modes as found in 
proteins. To estimate the structural contents of unknown proteins 
from the ca1culated reference spectra, the CD spectra for a number of 
trial compositions are made and compared with the experimental spectrum 
of the unknown composition in order to find optimal fit by visual in-
spection~ or the adjustment for best fit can be done by means of a 
least squares program. 
6. EXPERIMENTAL PROCEDURE 
6.1 Preparation of Materials 
6.1.1 Quantification of Plasma Proteins 
Fresh platelet poor plasma (PPP) was obtained from the Univer-
sity Hospital and this PPP was filtered through 0.22 11m ~1i1lipore fil-
ter to remove remaining cells. This plasma was used to protein ad-
sorption onto polymer surfaces after each protein component vias quanti-
fied. 
Reagents: 
Biuret diluent; KI 0.5 percent (w/v) in 0.25N NaOH. 
Stock biuret reagent; an amount of 7.5 grams finely pulverized 
CuS04.5H20 was dissolved in 40 ml of distilled water. This solution 
was slowly added, stirring, to 22.5 9 of Rochelle salt dissolved in 
40 ml of biuret diluent at room temperature. Total volume was adjusted 
to a volume of 500 ml and any cuprous oxide deposit was removed just 
before use. 
Working biuret; the stock biuret reagent was diluted 1:5 with 
biuret diluent. 
Sal ine; 0.85 percent NaCl (w/v) in water. 
Working dye reagent for albumin assay; methyl orange dye solu-
tion, whose absorbance at 540 mu lies between 0.78 and 0.85, in O.055M 
citrate buffer (pH 3.5). 
~!olfson's gamma-globulin reagent; 19.3 percent (NH4)2S04 
(w/v) in 4.0 percent NaCl (w/v). 
Thrombin solution; 5000 NIH units per mil. 
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Ground pyrex glass; glass particles of their diameter 0.5 to 
1.0 mm were prepared and washed with 0.05 N NaOH and 0.10 Hel. They 
were rinsed thoroughly with water and air dried. 
6.1.1.1 Total Protein in Plasma (182) 
Protein standard solution (8.0 g/lOO ml, Sigma, Stock No. 
540-10) diluted 1 :10 with saline was used for calibration. The volumes, 
0.50, 1.00, 1.50, and 2.00 ml of the diluted standard solution were 
transfered to each cuvet, and adjusted to a volume of 2.10 ml by add-
ing saline. A volume of 8.0 ml working biuret was added to each cuvet, 
followed by thorough mixing. The absorbance after 30 minutes of color 
development was measured at 550 nm with blank set at 100 percent T. 
The blank contains 2.1 ml saline and 8.0 ml working biuret. The slope 
of a plot of concentration versus absorbance was used as the multi-
plication factor for determining an unknown concentration of plasma 
proteins. A volume of 0.1 ml plasma was pipetted into a cuvet contain-
ing 2.0 ml saline, and 8.0 ml working biuret was added. After 30 
minutes of color development, the absorbance of the solution at 550 nm 
was measured with blank set at 100 percent T and multiplied by the 
factor F to obtain the concentration of total protein in plasma 
6.1.1.2 Garnma-globu1 in in Plasma (183,184) 
Calibration was made using human gamma-globulins (Cohen Fr. II, 
electrophoretic purity, approximately 99 percent; Sigma HG-ll) as a 
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standard. A volume of 9.60 ml Wolfson's reagent was pipetted into a 
thick walled 15 ml conical centrifuge tube and 0.40 ml plasma was 
layered on top. After mixing until completion of turbidity, the tube 
was centrifuged for 20 minutes at 2,000 g to get a white pellet. The 
supernatant was removed by suction and completely drained by invert-
ing on a filter paper. All the solution adhering to the side of the 
tube was wiped dry with a piece of rolled filter paper. A volume of 
2.0 ml water was added, shaken vigorously to dissolve the pellet. A 
volume of 8.0 ml working biuret was added and mixed vigorously. After 
30 minutes of color development, the absorbance at 550 nm was read 
against a blank containing 2.0 ml water and 8.0 ml working biuret. 
Plasma concentration of gamma-globul in vIas calculated from cal ibration 
slope. 
6.1.1.3 Fibrinogen in Plasma (185,186). 
A volume of 8.0 ml saline, 1.0 m1 phosphate buffer (0.2 M, 
pH 6.3) and 0.5 ml plasma were mixed well in a 15 x 125 mm test tube 
containing 0.5 gm of ground glass. A volume of 0.1 ml thrombin solu-
tion (500 units) was added rapidly and mixed immediately by tapping 
vigorously enough to suspend most of the ground glass several centi-
meters up into the solution in the tube. The tube was left undisturbed 
for approximately 5 minutes until clotting was completed and a solid 
gel was formed. The formed gel was loosened from the side of the 
tube by tapping. After being left standing for another 5 to 10 
minutes to achieve complete clotting, the tube was centrifuged for 10 
minutes at 2000 g. The glass particles, enmeshed in the clot, forced 
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the clot to sediment to the bottom of the tube in the form of a clot-
glass pellet. The clot-glass pellet and the side of tube was washed 
twice with saline, and the supernatant was decanted as completely as 
possible. After adding a volume of 2.0 ml NaOH (3.0%), the tube was 
heated with a shaking action for 15 minutes in a boiling water bath 
to dissolve the fibrin clot. A 4.5 ml volume of working biuret was 
thorughly mixed with the cool fibrin solution. After 30 minutes of 
color development, the absorbance at 550 nm was measured against a 
blank containing 0.5 gm ground glass and 2.0 m1 NaOH solution (3.0%). 
Fibrinogen concentration was determined from a calibration slope made 
using pure human fibrinogen (96% clottable protein, IMCO). 
6.1 .1 .4 A 1 bumi n in Pl asma U:lethyl Orange 
Binding) (187). 
The calibration was made using 5 percent sterile albumin solu-
tion (Sigma, A 4628) as a standard. A 10.0 m1 volume of working dye 
was mixed well with 0.2 ml plasma in a test tube. The test tube was 
left undisturbed for 20 minutes for the equilibrated binding of the 
dye to albumin. The absorbance at 540 nm was read against a blank 
which contained saline instead of plasma. Albumin concentration was 
determined from the ca1ibraiton factor. 
6.1.2 Purification of Fibrino~~ 
All fibrinogen used was purified by Laki method in the follow-
ing manner (188): Two grams of bovine fibrinogen (Sigma; fibrinogen, 
Fr. I, over 60 c1ottable, F 400) was dissolved in 100 ml of 0.1 M 
phosphate buffer (pH 6.41). The solution was diluted with 100 ml 
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water (pH 6.52), and left standing overnight in a refrigerator. The 
formed precipitate was filtered off at room temperature. After centri-
fugation, the clear solution \",as again filtered through 0.45 mll Milli-
pore filter. To this clear solution, one-third volume of saturated 
ammonium sulfate was added at room temperature in small portions with 
constant slow sitrring. The flocculent white precipitate was centri-
fuged, and dissolved in 60 ml of 0.3 M KCl at room temperature, the 
pH of the KCl solution being brought to about 7.4 by the addition of 
a small amount of ammonia. The water-clear solution was dialyzed 
against 1 liter of 0.3 M KCl in a refrigerator for three days. The 
KCl dialyzing solution was changed every day. The purity of fibrinogen 
was determined in terms of percentage of clottable protein. The frac-
tion of clottable protein was obtained by comparing the optical densi-
ties at 280 nm of the purified fibrinogen and a supernatant fluid after 
removing a thrombin-induced clot. The purified fibrinogen solution 
was diluted 20 times in 0.1 M KCl and its U.V. absorbance at 280 nm 
was measured. The supernantant, after clotting, was obtained by mix-
ing 1.0 ml of the purified fibrinogen, 0.1 ml of phosphate buffer 
(0.5 M, pH 6.3), 2.5 ml water, and 0.1 ml thrombin solution (25 units). 
The turbid clot was removed one hour later, and the optical density 
of the supernatant was measured and corrected by diluting factor. The 
fraction of clottable protein was expressed as one minus the ratio of 
optical densities of the supernatant and the pure fibrinogen solution. 
Only fibrinogen of over 95 percent clottable protein was used for the 
studies. 
6.1.3 Immobilization of Proteins to 
Sepharose Beads (189) 
6 . 1 . 3. 1 Fib r i no ge n, Ga mma - g lob u 1 in, 
and Albumin 
67 
Activation of Sepharose 2B: An amount of 5 gm CNBr was dis-
solved in water under a vented hood. A slurry of Sepharose 2B (50 m1) 
washed with water was then added to the cyanogen bromide (CNBr)-water 
mixture. The pH of the reaction mixture was adjusted to 11.0 and 
maintained for 10 minutes by adding 4 N NaOH from a buret. The 
temperature of the reaction mixture was kept below 25°C by the addi-
tion of crushed ice or using an ice bath. The activated Sepharose 2B 










Figure 16. Activation of Sepharose beads. 
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Coupling of proteins to activated Sepharose 28: Protein solu-
tion in 0.1 M NaHC0 3 buffer containing 0.5 N KC1 (pH 8.3) (Fibrinogen, 
15 mg/Illl; gamma-gl obul in, 12.0 mg/ml; a 1 bum; n, 22.5 mg/rnl) \~as m; xed 
immediately \'Iith the activated viet beads. The mixture was stirred 
gently for over 16 hours at 4°C. The resultant fibrinogen/Sepharose 
28 was washed with 15 volumes of the cold coupling buffer (0.1 M 
NaHC03, 0.5 N KC1, pH 8.3). The possibly remaining active sites were 
deactivated by blocking with glycine overnight at 4°C in 1 M glycine 
solution in the same carbonate buffer. The amount of immobilized pro-
tein was determined by the change in concentration of protein solution 
after immobilization. The concentrations of the proteins were de-
termi ned by ul tra vi 01 et spec trometry us in 9 a Ca ry r·1ode 1 15 recordi ng 
1 0/ 
spectrometer and absorption coefficients, El~m at 280 nm, 15.5 for 




~o- C -NH-Protein II OH 0 
Figure 17. Immobilization of protein to activated beads. 
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The amount of immobilized proteins in 1 m1 of beads was ap-
proximately 8.0 mg for fibrinogen, 11.0 mg for gamma-globulin, and 18 
mg for albumin. The excess glycine and adsorbed protein were washed 
off with a sequence of: the coupling buffer, acetate buffer (0.1 M 
acetate, 0.5 M KC1, pH 4), and coupling buffer again. The beads were 
kept in 0.1 percent sodium azide solution of coupling buffer in a re-
frigerator. These protein-immobilized Sepharose 2B beads were used 
for the platelet retention study after enzyme treatment. 
6.1.3.2 Enzymes (Lactoperoxidase, Galactose 
Oxidase, and f'Jeuraminidase) 
Preactivated Sepharose 4B was used for immobilizing enzymes to 
beads. An amount of 0.5 gm dried CNBr-Sepharose 48 (Pharmacia) was 
swollen and washed with 10-3 N HC1. The swollen beads were washed 
with PBS buffer (0.01 M phosphate, 0.1 N NaCl, pH 7.5). A given amount 
of enzyme (lactoperoxidase, Sigma, 5 mg or 200-500 units; galactose 
oxidase, Sigma, 450 units; neuraminidase, Behring, 500 units) was dis-
solved in 5 ml of PBS (pH 7.5) in a plastic culture tube. The activated 
Sepharose 4B was added to the tube and agitated overnight in a rotating 
shaker. The enzyme-bound beads were thoroughly washed on a Buchner 
glass filter with the coupling PBS. The remaining active sites of the 
beads were deactivated by exposing them to 0.2 M glycine in the coupl-
ing PBS buffer at 4°C for over five hours. The amount of immobilized 
enzymes was determined from the decrease in concentration of the enzyme 
solution after immobilization reaction. The concentration of lacto-
peroxidase solution was determined from its optical density at 412 nm 
(E~;12nm = 114, M\~ = 7800) us i ng a Ca ry f'10de 1 1 5 s pectropho tome ter . The 
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change in concentration of galactose oxidase and neuraminidase was 
determined by a modified Folin Ciocalteau method which is highly seni-
tive to a very small quantity of protein (190). The amount of immo-
bilized enzyme in 1 ml of wet beads was about 2.3 mg for lactoperoxi-
dase, 2.1 mg for galactose oxidase, and 2.8 mg fer neuraminidase. 
After being thoroughly washed, the lactoperoxidase-bound beads were 
used for labelling r125 to proteins, and the galactose oxidase- and 
neuraminidase-bound beads for treatment of plasma proteins. 
6.1.4 Enzymatic Radioiodination of 
Plasma Proteins 
There are three procedures available for labelling 1125 to pro-
teins. The chloramine-T method is known as an efficient method for 
the direct substitution of r125 into the tyrosine residues of proteins 
(191,192), but it has been indicated that high concentrations of such 
a powerful oxidizing agent cause the denaturing of proteins (193,194). 
The second procedure is a treatment of proteins with an r125-1abelled 
acylating agent, iodinated 3-(4-hydroxyphenyl) propionic acid N-hydroxy 
succinimide ester, which reacts with free amino groups in the protein 
molecule to attach the I125-1abelled groups by amide bonds (195). This 
procedure not only involves reacting the protein under mild conditions 
with the Il25-containing acylating agent, but also has an advantage of 
labelling peptides or proteins that lack tyrosine. The third procedure 
is using a mildly oxidizing enzyme, lactoperoxidase, in order to cata-
lyze direct iodination of tyrosines in proteins ("196-201). The lacto-
peroxidase method appears to be quite gentle, employs low levels of 
relatively weak oxidizing agent, and can yield products with high 
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specific activities. The following reaction shows the lactoperoxi-
dase-catalyzed iodination of proteins: 
S 
125 o=c 
.Lactoperoxidase. H20 tOH 
1 \ 
+ HO-h CH-CH \:/'i 
HN ) 
The iactoperoxidase procedure can be done more effectively without the 
introduction of contaminants into the iodination reaction mixture by 
using solid state lactoperoxidase, the enzyme immbi1ized to Sepharose 
4B (202,203). This procedure was adopted for radioiodination of plasma 
proteins (fibrinogen, gamma-globulin, and albumin). A concentration, 
5-7 mg per ml of protein solution in PBS (0.01 M phosphate, 0.145 N 
Nael) was used for labelling r125 to the proteins. A volume of 0.03 
ml lactoperoxidase-immobilized beads, equivalent to 75 11g lactoperoxi-
dase, was suspended in 4 ml of protein solution in a capped test 
tube. A vol ume of 4 of KI -2 ( 10 1'1) Itla s added to obtain the 1<1 
final concentl~a t ion -5 of 10 r1, followed by addition of 1 mei radio-
labelled sodium iodide (r 125 ). The labelling reaction was initiated 
by adding 9 ~l of 0.03 percent H202 solution (final concentration, 
'"l 10- 5 ~~\ t:.. x 1'1; • After 48 - 60 minutes of reaction time at room 
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temperature, the reaction tube was centrifuged at 2000 g for 10 min-
utes. The supernatant was eluted through a Sephadex G-25 (coarse) 
column equilibrated with 0.1 percent protein solution in PBS buffer 
(0.01 M phosphate, 0.145 M NaCl). Two milliliters of elution solution 
was collected in each fraction at the rate of 1.0 ml per minute. Less 
than 0.01 percent free r125 remained after eluting through columns 
three times. Figure 18 shows the elution profile for the first and 
the second elutions. The immobilized iodine was significantly re-
leased as free iodide after several days. Therefore, freshly labelled 
protein solution was used for all experiments. 
6.1.5 Enzyme Treatment of Proteins 
Blood glycoproteins (fibrinogen and gamma-globulin) were 
treated with enzymes such as galactose oxidase (Sigma, G 0875, 100 
units per mg solid) and neuraminidase (Behring, 500 units per m1) in 
order to modify the terminal sugar residue as shown in Figure 19. The 
treatment was accomplished in four different reaction systems for each 
enzyme treatment. 
The first system includes a treatment of the blood glycopro-
teins with immobilized solid state enzymes. A volume of 3 ml r125_ 
protein solution (3-4 mg/ml) was mixed with 7 ml of cold protein 
solutions (about 15 mg/ml) in PBS (pH 7.0, 0.01 M phosphate, 0.145 N 
NaCl). A volume of 10 ml diluted rl -protein solution or only non-
labelled protein solution was slowly rotated with enzyme-bound Sepha-
rose 48 overnight at room temperature with galactose oxidase and four 
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Figure 18. The elution diagram of gel filtration of r125-1abelled 
fibrinogen. ---- = first elution, ---- = second elution. 
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( b ) 
Gal 
Figure 19. Enzyme treatment of glycoproteins. (a) = galactose oxi-
dase catalyzed reaction, (b) = neuraminidase catalyzed 
reaction, Gal = galactose, SA = sial ice acid. 
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to blood protein ratio, 1 :50) was carried out at pH 7.0 and neura-
minidase (protein ratio, 1 :35) in a system containing 10-3 i'-1 CaC1 2 at 
pH 6.0. The supernatant of the enzyme-treated protein solution was 
separated from the beads by centrifugation. The native protein solu-
tion used as a control was not treated with enzymes, but with deacti-
vated CNBr-Sepharose 4B without enzymes by the same method previously 
described for the enzyme-bound Sepharose 4B. The deactivation of 
CNBr-Sepharose 48 was accomplished by reacting CiJBr-Sepharose 4B with 
0.2 M glycine overnight at 4°C. The protein solutions were adjusted 
to pH 7.4 and used for the studies on platelet interaction with those 
proteins. Enzyme-treated cold protein solution was used in the studies 
on platelet aggregation and circular dichroism. 
In the second reaction system, protein was treated with enzymes 
in a solution system. A 10 m1 volume of protein solution (20 mg/ml) 
in PBS was incubated with galactose oxidase (450 units) four hours at 
37°C overnight at room temperature. The protein solution was diluted 
with the same volume of Tris-maleate buffered saline (0.02 r~ Tris-
-3 maleate, 0.145 NaCl, 10 M CaC'2) and adjusted to pH 7.4. A neura-
minidase treatment was made by incubating a mixture of 10 ml protein 
solution in Tris-ma1eate buffered saline and 500 units of neuramini-
dase for four hours at 37°C. After the same volume of PBS (pH 7.0) 
was added to the solution, its pH was adjusted to 7.4. These enzyme-
treated protein solutions I_~ere used for the studies on protein-induced 
platelet release of serotonin. 
The third reaction system used proteins immobilized to Sepha-
rose 28 as an substrates for enzyme solution. Neuraminidase (500 units) 
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and galactose oxidase (450 units) were dissolved in a total volume of 
10 ml acetate buffer (pH 5.5,0.05 Macerate, 0.9% NaCl, and 0.1% 
CaC1 2) and PBS (pH 7.0, 0.01 M phosphate, 0.145 M NaCl), respectively. 
An amount of 6 mg beads was suspended in each enzyme solution and 
incubated for three hours at 37°C. All the enzyme-treated beads were 
washed thoroughly with PBS (pH 7.4,0.01 M phosphate, 0.145 N NaCl), 
followed by Tyrode buffer solution. These solid state plasma proteins 
were used for platelet retention studies. 
The fourth procedure included an adsorption of plasma proteins 
onto a Mylar surface and a treatment of the adsorbed proteins with 
enzymes. A microscopically smooth t1ylar surface adsorbed a protein 
layer in a protein solution in PBS (concentration, 10 mg/ml, pH 7.4, 
0.01 M phosphate, 0.145 N NaCl) for two hours at 37°C. Each of the 
protein-coated surfaces was rinsed with PBS (pH 7.4), and enzyme-treated 
by soaking each surface in its respective enzyme solution (made in the 
same way as the third reaction system) for one hour at 37°C. A non-
protein-coated surface used as a control was soaked in each of the 
enzyme solutions in the same way as the protein-coated surfaces. These 
surfaces were observed under scanning election microscopy and light 
microscopy for determination of platelet adhesion onto the protein-
coated surfaces. 
The treatments of proteins with galactose oxidase and neura-
minidase were identified by a chromagen coloration method (204) and 
thiobarbitur;c acid assay of sialic acid (205), respectively. The 
hydrogen peroxide formed in the oxidation of proteins with galactose 
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oxidase was utilized for the coupled oxidation of a suitable chromagen 
to yeild a colored product. 
H202 + Chromagen (o-dianisidein) 
The absorbance at 420 nm was read, which is proportional to the con-
centration of H202. In this reaction horseradish peroxidase was added 
to catalyze the perox;dation of the chromagen o-dianisidine. A range 
of 0.7 - 1.0 ~ moles of galactose was oxidized with 100 mg of fibrino-
gen and 0.5 - 0.8 ~ moles of galactose with the same amount of gamma-
globulins in the conditions described previously. In the assay of 
sialic acids, the sialic acid released from proteins was oxidized in 
a strong acid solution by sodium periodate and coupled with thiobarbi-
turic acid, which develops color. An absorbance at 549 nm of the color 
extracted into cyclohexanone was read. One hundred mg of fibrinogen 
released a range of 0.7 - 1.3 ~ moles of sialic acid and gamma-globulins 
released a range of 0.5 - 0.8 w moles in the conditions described. 
6.1.6 Soldium Periodate Treatment of Proteins 
The carobhydrate mOiety of fibrinogen and gamma-globulin ~vas 
oxidized in two systems using dilute sodium periodate solution in the 
same conditions as Laki (206) used for fibrinogen. It was indicated 
that periodate oxidizes only the carbohydrate moiety under these con-
ditions, and that after two hours of reaction with periodate the 
fibrinogen loses about 30 percent of its hexose and 43 percent of its 
sialic acid content and no hexosamine. 
In one system, a volume of 1.0 ml of periodate solution (0.1 N) 
was mixed with 9.0 ml of protein solution (20 - 25 mg/~l) in phosphata 
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buffer (pH 7.0, 0.01 M phosphate, 0.145 N KCl) by adding it to the 
latter, slowly drop by drop with mild stirring. After an oxidation 
reaction for a given time (1 hour, 2 hours, 3 hours) at room tempera-
ture, the reaction mixture was dialyzed in PBS (0.01 M phosphate, 
0.145 N NaC1) at 4°C for three days during which the dialyzing medium 
was changed three times. Nonoxidized protein solution used as a con-
tro1 was also dialized in the same way as oxidized protein solution. 
In the other system, proteins adsorbed onto r~lar were treated 
by soaking the protein-coated membrane in the dilute periodate solu-
tion for a given time at room temperature. The membrane was rinsed 
with PBS, followed by iyrode solution, and used for platelet adhesion 
onto the pro in-coated surface. 
6.1.7 Preparation of Platelet Rich Plasma (PRP) 
and Washed Platelets 
Nine volumes of fresh bovine blood were collected into one 
volume of 3.8 percent trisodium citrate at a local slaughter house. 
Platelet rich plasma (PRP) was obtained by centrifuging the blood in 
50 ml polycarbonate centrifuge tubes at 2700 rpm (1200 g) for five 
minutes at room temperature using a horizontal type of MSE centrifuge. 
Washed platelets were prepared by albumin density gradient 
separation (ADGS)(207) which was slightly modifiEd to enrich the con-
centration of platelet suspension. A 40 - 45 percent (w/v) aqueous 
albumin solution was made by layering bovine albumin (Sigma, Fr. V) 
over the top of 100 ml of distilled water and left standing without 
stirring at 4°C for 48 hours. Calcium-free Tyrode solution was used 
for washing and suspending the platelets. The iyrode solution, whose 
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composition is NaCl 8.0 g/l, KCl 0.2 g/l, NaHC03 1.0 g/l, NaH 2P04 .2H20 
0.065 g/l, MgC1 2.6H20 0.415 g/l, dextrose 1.0 gil was prepared from 
three stock solutions which are as follows: 
1. NaCl 160 g/l; KCl 4 g/l; NaH 2P04 .H20 1.15 gil. 
2. NaHC03 20 g/l. 
3. MgC1 2l6H20 8.29 g/l. 
To 100 ml dextrose were added 5 ~l volumes of each of these three 
solutions, and the mixture was made up to 100 ml with distilled water. 
A 50 ml polycarbonate centrifuge tube with 4 ml of 40 - 45 
percent albumin in the bottom was stored at -20°C until use. With the 
albumin still frozen, 40 ml of freshly collected PRP was layered over 
the albumin, which was allowed to melt. The interface between the 
albumin and the PRP was gently agitated with a siliconized glass or 
plastic stirring rod, using vertical movements over a distance of ap-
proximately 1· cm unti 1 a density gradient approximately 1 cm broad 
was prepared. The tube was then stoppered and centrifuged at room 
temperature for 15 minutes at 2000 g (3500 rpm) in a horizontal type 
of MSE centrifuge. The relatively platelet poor plasma in the superna-
tant is then rernoved with a sterilized disposable plastic pipette and 
resuspended in 20 ml of Tyrode solution containing 3.0 gm/l albumin. 
This first platelet suspension was centrifuged again on an albumin 
cushion for eight minutes at 2000 9 (3500 rpm) and resuspended in the 
same way as previously described. After the separation process was 
repeated once more, the final concentration of platelets was adjusted. 
Platelets were also washed in the same way only using different 
washing and suspending fluids (208). The first washing fluid consisted 
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of NaCl (8.0 gm/l), KCl (0.2 gm/l), NaHC03 (1.0 gm/l), NaH 2P04 ,H20 
(0.05 gm/l), CaC1 2.2H20 (0.294 grn/l), MgC1 2.6H20 (0.203 gm/l), glu-
cose (1.0 gm/l), bovine albumin (3.0 gm/l). heparin (2500 units/l). 
The second or further washing fluid and suspending fluid had the same 
composition as the first one excluding heparin. 
6.1.8 Platelet Counting 
6.1.8.1 Phase Contrast i1icroscopy (209) 
An ammonium oxalate solution was used as the diluent for plate-
let-rich plasma. A 1.1 gm amount of ammonium oxalate was dissolved in 
distilled water and made to a total volume of 100 ml. This solution 
was always stored in a refrigerator to avoid growth of bacteria. 
Platelet-rich plasma was drawn into a red cell pipette to the one mark 
with great accuracy. The pipette was filled with the diluent to the 
101 mark and shaked for approximately three minutes. After four drops 
were discarded, a hemocytometer covered with a No. cover glass was 
filled with platelet suspension from the pipette. The preparation was 
allowed to stand in a moist chamber (an inverted Petri dish with a 
piece of wet filter paper) for 15 minutes. The platelets in the four 
corner squares and the central square were counted at 40 x 15 multiple 
pm",er by phase contrast using Nikon Model VBS microscope. 
No. of cells counted x dilution = No. of platelets/mm3 
No. of squares counted x 0.004 
6.1.S.2 Coulter Counter (210) 
A 30 percent potassium oxalate solution and a 0.9 percent sa-
line solution \I/ere prepar'ed and filtered trlrough a 0.45 llftl i·lillipore 
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filter, tv/ice each. The saline was mixed with the potassium oxalate 
solution and filtered through the 0.45 ~m Millipore filter just be-
fore its use as the platelet-rich plasma diluent. 
A coulter counter (Industrial r~odel B) with 70 llm aperture 
and a 2-position manometer (0.1 ml and 0.5 ml) was used for counting 
platelets after the machine was calibrated. The amplification and 
the aperture current controls were set, using platelet-rich plasma, so 
that the platelet distribution peak was at one-third the height of the 
oscilloscope screen. The plateau between the background and the plate-
let distribution was identified at the upper threshold setting of 50 
by running a sample with a relatively high platelet counts at increas-
ing settings of the lower threshold. The fine gain was controlled so 
that the plateau could appear at lower threshold setting of 6-7. The 
machine in our laboratory was adjusted as follows: 
Upper threshold 50 
Lower threshold 7 
Amplification 1/4 
Aperture current 1/4 
Aperture matching switch 64L, manometer 0.1 position. The 
fine gain control as set at 50. 
A 5 III capillary pipette was filled with plasma or washed 
platelet suspension and diluted in 100 ml of PRP diluent in a silicon-
ized beaker used as a counting chamber. For low platelet counts, a 
10 ul pipette was used. A certain number of multiple passage are in-
evitable when cell particles transverse the critical sensing zone of 
the orifice. Such a coincidence loss was corrected by using a 
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coincidence correction chart provided in the manual. For platelet 
counting from small amount of blood, Bull 's sedimentation technique 
was used (210). 
6.1.9 Immobilization of D-Galactose 
to Sepharose 2B 
D-Ga1actose was immobilized to Sepharose 28 by using s-amino 
caproic acid as a spacer group essentially as described in Gordon's 
method (211) which is also described schematically in Figure 20. 
6.1.9.1 Preparation of a p-D-Galactopyransosylamine (211,212) 
Ammonia gas was bubbled into D-glactose supsension (27 gm, 
150 mmole) in 200 011 of liquid ammonia in methanol (25% v/v) until ali 
the galactose was dissolved. After standing in a closed vessel at 
room temperature for one week, the precipitate, which consists of a-D-
ga1actopyranosy1amine was discarded. The supernatant was kept in a 
closed vessel under a vented hood at room temperature for another 3-4 
days; during this period the vessel was opened every day for 1-2 hours 
to p~rmit the evaporation of excess ammonia. The desired 8-iso~er of 
D-g1actopyranosylamine was crystallized. The precipitate was collected 
by filtration, washed with absolute methanol and dried in a vacuum des-
sicator over NaOH. Yield was about 28 percent and its melting point 
was 136-137° (reference 209, yield 25%, m.p. 136-137°). 
6.1.9.2 N-Benzy1oxy carbony1-s- aminocaproic acid (213) 
A 5.24 gm amount of s-amino caproic acid was dissolved in 125 
m1 of 4 N NaOH and stirred in a 500 ml three-necked flask in an ice 
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~o ~ ) C=N-NH-AG o 0 
~ :0" . ~~NH-AG SAG 
OH NH 
~O-C-NH-AG 11 OH 0 
Figure 20. Immobilization of galactose to Sepharose 28. G = Galac-
tose, GA = Galactopyranosylamine, BAG = N-(N-Benzyloxy-
carbonyl-2-aminocaproyl)- galactopyranosylamine, AG = N-
£-aminocaproyl-B-galactopyranosylamine, SAG = Sepharose-
N-s-aminocaproyl D-galactopyranosylamine. 
bath. A 250 ml volume of 4 N NaOH and 0.75 moles (or 107 m1) of 
carbobenzyloxy chloride (benzylchloroformate) were slowly added 
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simultaneously, maintaining the cool temperature. After being stirred 
for one hour at room temperature, the reaction mixture was extracted 
with diethy1 ether and the aqueous phase was acidified to precipitate 
s-carbobeny1oxyamino caproic acid. After the precipitate was recrystal-
lized from CC1 4, its melting point was determined to be 54 - 55°C 
(from reference 209, m.p., 54-55). 
6.1.9.3 Preparation of N-(N-Benzyloxy 
carbonyl-£-amino caproyl)-
galactopyranosylamine (211) 
Isobutyl choloformate (10 mmole, 1.3 1111) and triethylamine 
(10 mmoles, 1.4 ml) were slmvly added to a solution of N-benzyloxy-
cargonyl- -amino caproic acid (10 mmoles, 7.98 gm) in 17 ml dimethyl-
formamide, kept at -SoC. The mixture was stirred for 20 minutes at 
-5°C and then filtered. The filtrate was immediately added to a sus-
pension of S-D-gaiactopyranosylamine (8 mmoles, 1.44 9m) in 17 ml of 
dimethylformamide and the mixture stirred at room temperature until 
the solution was clear. The solution was allowed to stand at room 
temperature for 16 hours after which the solvent was removed in vacuo. 
The residue was crystallized twice from ethanol. The yield was 52 per-
cent with a melting point of 158 - l60 a C (from reference 209, lS9-l60°C). 
6.1.9.4 Preparation of N-£-Amino capryoly-B 
-D-galactopyransolylamine (211) 
N-(N-Benzyloxy carbony1-£-amino caproyl )-C-D-galactopyranosy-
lamine (6 rnmoles, 2.56 gm) in 80 percent aqueous methanol (60 m1) was 
hydrogenated over palladium on charcoal (10%, 60 mg) at atmospheric 
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pressure for 10 hours at room temperature. The mixture was crysta1-
liZed from a methanol-ether solution and the yield was 70 percent with 
a m.p. of 206 - 208°C (from reference 209, 207-208°C). 
6.1.9.5 Immobilization of N-E-Amino 
caproyl-8-D-ga1actopyranosy-
lamine to Sepharose 2B (189) 
The CNBr-activated Sepharose 2B was prepared in the same way as 
previously described in the preparation of solid-state plasma proteins. 
The activated Sepharose 2B was washed rapidly with 15 volumes of cold 
water on a Buchner glass filter. A volume of 50 m1 of wet Sepharose 
2B was then added quickly to a solution of N-E-amino caproy1-S-D-
galactopyranosy1amine (3.0 mmo1es in 20 m1 of 0.5 M NaHC0 2) and the 
mixture was stirred gently for 16 hours at 4°C. The conjugate of Sepha-
rose 2B-galactose was filtered and washed thoroughly with 0.1 M NaHC0 3 
and water. The amount of D-ga1actose derivative covalently bound to a 
the Sepharose was determined by the hydrolysis of the beads in 6 N HCl 
(22 hours, 110°C) and the estimation of the liberated s-amino caproic 
acid using an amino acid analyzer (Beckman-Spinco). One milliliter of 
the Sepharose 2B was found to contain about 3.7 moles of covalently 
bound N-E-amino caproy1-S-D-galactopyranosylamine. 
6.1.10 Degradation and Denaturation 
of Fibrinogen 
Proteolysis of fibrinogen by plasmin (Sigma, F 6752; 1-2 units 
per mg) was carried out by the mixing of both components in a ratio of 
100:3 respectively (88,214). The reaction was conducted at 37 c C in a 
one percent bovine fibrinogen so1ution in 0.05 M sodium phosphate 
86 
buffer at pH 7.8. After 24 hours of digestion, soybean trypsin inhi-
bitor was added and the digestion mixture was extensively dialyzed 
against water for three days. The solution was cooled to O°C and 
diluted 10 times with ice-cold water. This solution was brought to 
pH 5.3 by addition of 1 M acetic acid and left at ooe overnight. 
The precipitate formed was discarded and ethanol precooled to -15°C 
was slowly added to the supernatant to a final concentration of 
25 percent (v/v); at the same time the temperature of the solution was 
adjusted to -5°C. After two - three hours, the fine precipitate formed 
was collected by centrifugation, suspended in ice-cold distilled water 
and freeze-dried. This product consists mainly of fragments E and D. 
Proteins were partially denatured by U.V. irradiation. A one 
percent protein solution was irradiated with U.V. light for six hours 
until just before the solution became cloudy. 
6.2 Adsorption of Plasma Proteins Onto 
Various Polymer Surfaces 
Fresh human plasma, after filtration through a Millipore fil-
ter (0.22 um}and concentration determinations of main proteins, was 
used for adsorption studies. Human proteins (albumin, fro V; gamma-
globulin, fro II; fibrinogen, fro I from Sigma Co.) were labelled with 
r125 using solid-state lactoperoxidase as described previously. r125_ 
labelled albumin was mixed with the plasma~ The polymer samples ",ere 
clamped in polycarbonate cells designed for static adsorption as shown 
in Figure 21. The samples were exposed to phosphate buffered saline 




( 8 ) 
Figure 21. Schematic diagram of static adsorption of proteins. 
(A) : Protein adsorption in waler bath at 37 c C; 
Test Cell Size, 4XiX2 em . 
(B) : Rinsing Pump: PBS is circulated through the 
cell at a flow rate of 10 ml/sec for 30 
seconds after adsorption, 
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for varying time intervals. After exposure, the samples were rinsed 
with phosphate buffered saline (PBS) at a flow rate of 10 cc/sec for 
30 seconds in order to remove excess clinging solution. The same pro-
cedures were applied for the adsorption of gamma-globulin and fibrino-
gen. The polymers used were Biomer (EThicon product), Avcothane (Aveo 
Everett), Silastic rubber (Dow Corning, medical grade), and fluorinated 
ethylene-propylene (Teflon FEP, Dupont). All polymer membranes were 
handled with gloved hands and soaked in PBS for three days just before 
adsorption. 
6.3 Interaction of Platelets with Plasma Glycoproteins 
6.3.1 Filtration Method 
Washed platelet suspension in Tyrode solution was adjusted to 
h 3 
a concentration of 1.0-1.2 x 10~ per mm. A 6 ml volume of platelet 
suspension was warmed up to 37°C in a screw-capped polystyrene culture 
tube using a water incubator. A volume of 100 ~l of I'25-1abelled pro-
tein solution (concentration, 10 mg/ml) was introduced into the plate-
let suspension, and mildly mixed and incubated at 37°C. One milliliter 
of the reaction mixture was drawn at each time interval and filtered 
through a 0.22 urn Millipore filter (Mil1ipore Co.). Sterilized, dis-
posable Falcon plastic pipettes were used for transferring the plate-
let suspension. The radioactivityof each platelet suspension and fil-
trate was measured using a Packard Scintillation Spectrometer. Al-
ternatively, the radioactivity of the filter paper was measured after 
washing. All experiments with platelets were completed within four 
hours from the time blood was collected. 
89 
6.3.2 Sedimentation Method 
A suspension of washed platelets in Tyrode solution \'Jithout 
- 3 
calcium was adjusted to a concentration of 6.0 x 100 per mm. After 
one milliliter of platelet suspension was heated to 37°C for 15 min-
utes in a polycarbonate tube using a water incubator, one milliliter 
of protein solution (native proteins or enzyme-treated ones) was in-
traduced into the platelet suspension and mildly mixed and incubated 
for 20 minutes at 37°C. The incubation mixture was centrifuged at 
12100 g after adding 3 ml of isotonic phosphate buffer (pH 7.4, 
0.01 M phosphate, 0.145 N NaCl). The platelet button was washed twice 
by resuspending it in the PBS and centrifuging at the same speed. The 
radioactivity of the platelet \',as determined using a Beckman Biogamma 
II counter and reduced to the amount of protein bound to 6.0 x 108 
platelets. 
6.4 Serotonin Release (215) 
Radioactive serotonin (2-C14-5-hydroxytryptamine) was incubated 
in 30 ml of washed platelets. A 2 ml volume of the readioserotonin-
absorbed washed platelet suspension was then incubated with 0.5 ml 
of protein solution in PBS (pH 7.4,0.01 M phosphate, 0.145 N NaCl) 
at 37°C. After 50 minutes of incubation, the reaction mixture was 
mixed with 0.2 ml of EDTA solution (134 mM in 66% aqueous ethanol), 
and cooled in an ice-bath. The mixture was centrifuged for 10 minutes 
at 12,500 9 and ODC. The radioactivity of O~2 ml of supernatant was 
measured using the Packard liquid Scintillation Spectometer. The con-
trol sample was prepared by incubating 2 ml of washed platelet 
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suspension with 0.5 ml PBS instead of the protein solution. The per-
centage of release was determined by relative changes of extracellular 
serotonin content to that of the control sample incubated with PBS. 
For determination of total radioactivity (extra- and intra-cellular), 
platelets were solubilized by mixing 2 ml of washed platelet suspen-
sion with 0.5 ml of 20 percent Triton X-100 instead of protein solu-
tion. Schematic diagram for the procedure is shownin Figure 22. 
6.5 ADP-Induced Platelet Aggregation (216) 
The Lambert-Beer law holds for particles in solutions and the 
optical density (or absorbance) is proportional to the number of cell 
particles present (217). When aggregating agent is added, platelets 
clump and the number of the cell particles decreases. The decrease 
in the number of particles during platelet aggregation is inversely 
proportional to its aggregating time. Thus, the platelet aggregation 
process can be measured as a function of time by the decrease of opti-
cal density of the platelet suspension. The rate and degree of aggy'e-
gation can be plotted by a recording device. 
In this thesis, platelet aggregation process was observed with 
a Chrono-log Model 335 aggregometer connected with Model 702 single 
channel recorder. A 0.31211 diamater cuvette was used with 0.5 ml of 
plasma or washed platelet suspension which were being stirred at 1200 
rpm by a teflon-coated stir bar and kept at a constant 37°C tempera-
ture. Aggregation was induced by a final concentration of 5 x 10-6 M 
AOP. The aggregometer was calibrated with PRP or washed platelet sus-
pension at maximum optical density (or minimum transmission) and with 
0,,5 ml protein 
solution 
1 





12,500 g, 10 mim. 
1 
0,2 ml supernatant 
(extracellular 5-HT) 
2 m1 of washed platelet 
suspension labelled with 
C14-serotonin 
0.2 ml EDTA 
solution 
1 
0.5 ml Triton X-1OO 






0.2 ml mixture 
(total activity) 
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0.5 ml PBS 
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Figure 22. Schematic diagram of the procedure for Serotonin release. 
PPP or platelet-poor suspension buffer at minimum optical density 
(or maximum transmission of light). 
6.6 Retention of Platelets in the Protein- and 
Galactose-immobilized Sepharose 2B Columns 
92 
Platelet retention by protein- or galactose-immobilized Sepha-
rose 28 was examined by pumping citrated blood through a small plastic 
syringe packed with a 1 ml bed volume of beads and the efferent blood 
was collected in 0.3 - 0.4 ml aliquots. Throughout the test, blood 
was maintained at room temperature. Blood was pumped through the bead 
columns at a rate of 0.3 - 0.4 ml/min. Prior to elution of whole blood, 
packed columns were \vashed Itlith 30 ml of Tyrode solution. After the 
first 0.4 ml of elution fraction was discarded, successive fractions 
were collected. Platelet retention was determined by measuring the 
number of platelets in the column fractions and was expressed as per-
centage of the platelet count in the whole blood prior to column ex-
posure. Platelets were counted with an electronic particle counter 
(~1odel B; Coulter Electronics, Inc., Hialeah, Fla.) (210). 
6.7 Light and Scanning Electron Microscopy 
A thick-walled polycarbonate tube with a threaded detachable 
base, on which a protein-coated polymer surface can be placed, was 
used for platelet adhesion. Platelet-rich plasma (PRP) was filled in 
the tube and incubated for one hour at 37°C. The platelet-adhered 
surface was rinsed with isotnic phosphate buffer at pH 7.4. The poly-
mer membranes were bathed in a warm (37°C) three percent glutaraldehyde 
in PBS (pH 7.4) for 30 - 40 minutes. They were thoroughly rinsed in 
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H0 0 for approximately five minutes. Each membrane was taken through 
L 
a graded series of ethanol in water solutions as follows: 10 percent, 
30 percent, 50 percent, 70 percent, 90 percent, 100 percent, 100 per-
cent ethanol for five to ten minutes each. They were subject to CO 2 
critical point drying for SEM. After the samples were mounted on SEM 
stubs using silver paint and/or double stick tape, they were coated 
with carbon and gold. For microscopic observation, the critical point 
drying step was skipped and alcohol-dehydrated samples were stained 
by soaking them in Paragon stain (Paragon C. and C. Co.) for five min-
utes and rinsed in water. A Nikon Biophot microscope was used at a 
magnification of 100 x 15 with oil immersion phase contrast. 
6.8 Circular Dichroism Measurements 
Circular dichroism vias measured with a JASeO J-40A automatic 
recording spectrometer at room temperature and under constant nitrogen 
flush. The CD instrument had been calibrated with an aqueous solution 
of d-10-camphorsulfonic acid. A 0.2 mm path-length cell was used with 
a range of protein concentration 0.08 percent - 0.13 percent in phos-
phate buffer (0.01 M phosphate, 0.015 M NaCl) at pH 7.5. The concen-
101 tration was determined using El~m of 15.5 for fibrinogen and 15.38 for 
gamma-globulin at 208 nm. All solutions were passed through a 0.45 
wm Millipore filter (Millipore Filter Co.) before measuring their CD 
absorptions. Circular dichroism results were reported in terms of [8J, 
the mean residue ellipticity in units of deg.cm2/dmole. The ellipti~ 
cities of all wavelengths were corrected by Lorentz correction factor 
of H20 at 25~C: 0.7725 for 300-240 nm, 0.7595 for 240-210 nm, 0.7420 
for 210-190 nm. In all proteins used, the mean residue molecular 
weight was taken as 115. 
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7. RESULT AND DISCUSSION 
7.1 Protein Adsorption 
The mechanism of platelet adhesion onto polymer surfaces in-
cludes primarily the reaction of platelets with adsorbed proteins. 
Therefore, protein adsorption, which controls the initial step of 
thrombosis, should be understood for the proposed mechanism. Static 
protein adsorption isotherms were determined for Biomer (Ethicon pro-
duct), Avcothane (Avco Medical), Silastic rubber (Dow Corning, medical 
grade), and fluorinated ethylene-propylene (Teflon FEP, Dupont). One-
half minute of rinsing at a flow rate of 10 cc/second after adsorption 
removed any excess protein. Adsorption data of albumin, gamma-globulin, 
and fibrinogen from human plasma are shown in the Figures 23, 24 and 
25, and Table 2. The data were taken by averages of three experiments 
with less than five percent error. The trend of the amount of adsorbed 
protein and the polymer dependence is similar to an earlier study of 
competive adsorption using much lower concentrations of proteins (25 
mg% albumin, 15 rng% gamma-globulin, and 7.5 mg% fibrinogen). Plateau 
times are similar for all adsorption data except for the longer adsorp-
tion periods of albumin on Siomer and fibrinogen on Teflon FEP. Of 
the four surfaces, Biomer has the highest amount of adsorbed albumin 
at both the first three minutes and the plateau surface concentration. 
Teflon FEP shows the lowest protein adsorption, especially albumin ad-














































































































































































































































































































































































































































































































































































Protein Adsorption from Human Plasma at 37°C 
3 Min. Plateau Con. Plateau Time 
Polymer (wmole/cm2)xlO6 {umol e/cm2)xl 06 (Min. ) 
Albumin 
Telfon FEP 0.73 3.48 60 
Silastic rubber 1 .88 10.4 60 
Avcothane 2.90 28. 1 70 
Siomer 5.51 43.2 100 
1:-Globulin 
Teflon FEP 0.44 2.08 60 
Silastic rubber 1 .48 4.04 80 
Avcothane 1 .68 4.94 80 
Siomer 3.00 6.04 80 
Fibrinogen 
Teflon FEP 0.14 0.83 100 
Silastic rubber 0.23 1 .26 80 
Avcothane 0.29 1.77 80 
Siemer 0.34 2.29 80 
100 
protein adsorption than FEP. Scanning electron micrographs have shown 
that Silastic rubber surfaces are very rough compaired to those of the 
other polymers (23). Rough surfaces provide a greater surface drea 
than physical dimensions predict. Threfore, the actual adsorption per 
unit area would be lower than reported here. Gamma-globulin and fi-
brinogen adsorptions also depend on the surface. However, the dif-
ference is not so great as in the case of albumin. This can be easily 
observed from Table 3 and Table 4 which show the mole ratio of adsorbed 
proteins with varying adsorption times up to 120 minutes. Since albu-
min is not responsible for platelet adhesion according to the proposed 
mechanism, it is of interest to determine the f'atio of adsorbed fibrino-
gen and gamma-globulin to adsorbed albumin. This expression of mole 
ratio will also cancel out the effect of surface roughness in comparing 
one polymer with another. In Table 3, the calculated ratio with Avco-
thane and Siomer is much less than that of Teflon FEP and Silastic 
rubber. This is largely due to the high adsorption of albumin onto 
Avcothane and Siomer. It was also found that the mole ratio of Teflon 
FEP would level off somewhat, though it would decrease with Biomer at 
about 60 - 80 minute adsorption time. A similar trend is shown in 
Table 49 that the mole ratios of Siomer and Avcothane decrease starting 
at 60 minute adsorption. Siomer and Avcothane are known to be less 
thrombogenic than other polymers and have been used for artificial 
heart fabrication by the Division of Artificial Organs at the Univer-
sity of Utah. It can be justified that Siomer and Avcothane are su-







































































































































































































































































































































































































































































based on the data in Tables 3 and 4, demonstrating the small ratio of 
adsorbed fibrinogen and gamma-globulin to adsorbed albumin. 
7.2 Interaction of Platelets with Glycoproteins 
As discussed in the proposed mechanism, platelets interact 
with glycoproteins of fibrinogen and gamma-globulin in the blood. Ac-
cording to the proposed hypothesis, sugar-transferase reactions are 
involved in the platelet-protein interactions and sugar termini such 
as galactose and N-acetylglucosamine of oligosaccharide chains are 
important in this interaction. To support this hypothesis, experi-
ments have been done with the emphasis on galactose, which is an abun-
dant terminal unit of fibrinogen and gamma-globulin of oligosaccharide 
chains. 
Two different methods, filtration and sedimentation, were used 
for determining the platelet-protein interaction. In the filtration 
method, the filtration through a Millipore filter (0.22 urn) was accom-
plished after the washed platelet suspension with a platelet concen-
tration of 1.0 - 1.2 x l05/mm3 was incubated in a radiolablelled pro-
tein solution (final concentration of protein, 33 ~g/ml). The results 
are shown in Table 5. The radiolabel1ed proteins retained on the fil-
ter after the completion of filtration were assumed to be the p1ate1et-
bound protein. The retention of the proteins due to adsorption had 
little difference between native and enzyme-treated proteins, and the 
adsorption was very small compared to the retention due to protein 
binding to platelets. The amount of native gamma-globulin retained on 


































































































































































































































































































































minutes incubation was defined to be the reference of 100 percent. 
Consequently, all radioactivities retained on the filters were calcu-
lated relative to the reference, as a percentage. The extent of 
fibrinogen and gamma-globulin bound to platelets decreased signifi-
cantly when the protein used was treated with galactose oxidase in 
order to oxidize -CH20H to -CHO of the C-6 position of terminal galac-
tose. An increased binding was noticed, when neuraminidase treated 
fibrinogen and gamma-globulin were used, due to the increased amount 
of terminal galactose exposed by the enzyme treatment. Protein bind-
ing with platelets occurred within five minutes during the experiment 
as designed, and slowly increased during the 30 minutes of the incuba-
tion period. 
In the sedimentation method, the retained protein with plate-
lets (6.0 x 108, total number of platelets present) was determined 
after a mixture of platelets and proteins was centrifuged at 12,500 
g for 10 minutes. The results are shown in Tables 6 and 7. In the 
range of protein concentrations examined, a significant decrease or 
increase of the interactions of the glycoproteins (fibrinogen and 
gamma-globulin) with washed platelets was observed using the glyco-
proteins treated with galactose oxidase or neuraminidase, respectively 
(P < 0.01). The treatment of proteins with neuramnidase may increase 
either the number of terminal galactose of each protein molecule or 
the population of protein molecules with terminal galactose to enhance 
the probability of complex formation with platelet membrane-bound 
enzymes. On the other hand, the decrease of the concentration of in-





































































































































































































































































































































































































































































































































































































































with the platelet membrane enzymes. It is also noted that platelet 
interaction increases more with fibrinogen than with gamma-globulin 
in all the concentrations of proteins. This is expected from the fact 
that gamma-globulin has less content of galactose. 
Most interactions appear to level off at a protein concentra-
tion of 0.5 mg/ml. However, the binding of neuraminidase-treated 
fibrinogen keeps increasing beyond this concentration. The results 
of the interactions are also presented graphically in Figures 26 and 
27. It was observed that in no case does the curve go through zero, 
suggesting that there is a population of high affinity sites being 
examined in this study. This evidence is strengthened from the double 
reciprocal plots in Figures 28 and 29 which are not linear through the 
range of concentrations examined. The binding of the high affinity 
sites appears to occur below the concentration of 0.05 mg/ml. More 
proteins are bound to platelets than expected from the binding of the 
low affinity range examined. It has been reported that four different 
populations of platelets, classified by their weight, interact with 
fibrinogen to differing extents (218). About 60 percent of the total 
bound radiolabelled fibrinogen is bound to an aged, light-weight popu-
lation of platelets, which could be considered as the high affinity 
site population. The other three populations of platelets interact 
with fibrinogen to a much lesser extent and could be considered as low 
affinity site populations. Adsorption of I125~fibrionogen on the light 
aged popuiations of platelets may be related to modifications of the 
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Figure 29. Double reciprocal plots of y-Globulin binding with plate-
lets: (.) Galactose oxidase treated, (I) Native, 
(A) Neuraminidase treated~ 
113 
unfolding of membrane structures which may be followed by more expo-
sure or unmasking of the reactive transferase enzymes for the 91yco-
proteins. 
Both methods of filtration and centrifugations have shown the 
same trend of platelet interactions. 
7.3 Serotonin Release 
Washed bovine platelets were incubated with radioactive 5-HT 
(serotonin) for one hour at room temperature to allow the uptake of 
serotonin into the platelet cells. The uptake percent was defined as: 
Percent uptake = X 100 
where CT represents total radioactivity (extra- and intra-cellular) 
after platelets were solubilized by Triton X-100, CE represents the 
extra-cellular radioactivity which was measured from supernant after 
centrifugation. The percent uptake ranged from 50 percent to 60 per-
cent. The platelets with radioactive serotonin were incubated with 
native or enzyme-treated proteins to see the effect of each protein on 
serotonin release. The extent of release was determined by the in-
crease of extra-cellular radioactivity after incubation with the re-
leasing agents. The percent release was calculated by the following 
formula: 
Release percent of 5HT X 100 
114 
where CEP represents the extracellar radioactivity after incubation 
with the releasing agents, proteins, and CEb represents the extra-
cellular radioactivity after incubation with isotonic phosphate buffer 
solution used for dissolving the proteins. 
Table 8 and Figure 30 show the effects of glycoprotein on 
platelet serotonin release by varying the concentrations of fibrinogen 
and gamma-globulin. The extent of release increases with protein con-
centration and levels off at high protein concentrations, indicating 
that protein binding to platelets is related to the release reaction 
as an initial step. Gamma-globulin induces more serotonin release than 
f1brionogen does at the same concentration, even if more fibrinogen 
is bound to platelets, indicating that inducing sites or structures of 
the proteins specific for platelets are required for release upon bind-
ing. 
Platelet serotonin release by native and enzyme-treated pro-
teins is given in Table 9 and Figure 31. The data were taken byaver-
ages of three experiments with given standard deviations using the 
same source of bovine biood. It is interesting to note that platelets 
serotonin release induced by the glycoproteins decreases significantly 
when using proteins treated with galactose oxidase, while the release 
is enhanced using proteins treated with neuraminidase (P < 0.01). 
This result ;s consistent with platelet interaction data, which indi-
cates the important role of the terminal galactose units of protein 
oligosaccharide chains in platelet interactions. Proteins interact 
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Figure 30. Dependence of protein-induced serotonin release upon 



































































































































































































































































































NA GA NE NA GA NE (NE) (GA) 
Effects of native and enzyme treated proteins on the 
release of 14C-serotonin: (.) Fibrinogen, (~) y-
Globulin, (0) Enzymes; NA, Native; GA, Galactose oxi-
dase treated; NE, Neuraminidase treated; (ME), Neura-
minidase enzyme; (GA), Galactose oxidase enzyme; final 
concentration of proteins, 1.6 mg/ml. 
119 
the oligosaccharide chain after which the release is then governed by 
not the galactose but the structural characteristics of the given pro-
tein. 
When the glycoproteins are treated with periodic acid, any 
sugar residue containing two or more -OH groups attached to adjacent 
carbon atoms in the oligosaccharide chains undergoes oxidation with 
cleavage of carbon-carbon bonds. It has been demonstrated that a ma-
jority of the carbohydrates of fibrinogen are selectively removed after 
oxidation for three hours under the conditions described in the experi-
mental section. Table 10 and Figure 32 show the average data of three 
experiments. Even after one hour of oxidation of the glycoproteins, 
the ability of serotonin release by the proteins fails almost com-
pletely. This is indicative of the important role that oligosaccharide 
chains of proteins play in platelet-protein interactions. 
As a control experiment, the effect of the enzyme itself on 
the serotonin release was also shown in Table 9 and Figure 31. When 
platelets were incubated with enzymes in the same conditions as used 
in the enzyme treatment of proteins, little release or even uptake of 
serotonin was observed. 
7.4 ADP-Induced Platelet Aggregation 
Washed platelet suspensions were prepared in two different buf-
fer systems as described in the experimental section. The effects of 
various proteins on platelet aggregation are shown in Figures 33 and 
34. Though aggregation of washed platelets caused by the low concen~ 
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Figure 32. Release of 14C~Serotonin from washed bovine platelets 
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Figure 33. Effects of native and enzyme treated fibrinogen on ADP-
induced aggregation of washed bovlne platelets (Final 
concentration of ADP, 5 x 10-6 M): (a) Fibrinogen, 
Ca+2; (b) Fibrinogen; (c) Neuraminidase treated; 
(d) Galactose oxidase treated; (e) Buffer instead of 















o :3 6 
TIME (MIN) 
Figure 34. Effects of native and enzyme treated y,..Globulin on Jl,DP-
induced aggregation of washed bovine platelets (Final 
concentration of ADP, 5 x 10~6 M; Final cQncentration 
of protein, 0.74 mg/ml): (a) Nati've, Ca+2 ; (b) Native; 
(c) Neuraminidase treated; (d) Galactose oxidase 
treated; (e) Buffer instead of protein solution. 
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was significantly increased by the addition of fibrinogen or gamma-
globulin (Figures 33b and 34b). The use of a calcium-containing buf-
fer system increased platelet aggregation by ADP (Figures 33a and 34a). 
The curves of ADP-induced aggregation by the presence of gamma-globulin 
are more steep than fibrinogen, indicating that the ADP-induced aggre-
gation was accelerated more by gamma-globulin. 
Galactose oxidase-treated fibrinogen and gamma-globulin (Fi-
gures 33d and 34d) resulted in decreased platelet aggregation with 
slower aggregation rates than with the use of native proteins for ADP-
induced aggregation. This result is consistent with the data shown 
in platelet-protein interaction and platelet release. Neuraminidase-
treated fibrinogen and gamma-globulin also showed similar trends but 
to a lesser degree though the highest platelet aggregation was expected 
due to the treatment of fibrinogen and gamma-globulin with neuramini-
dase resulting in increased exposure of galactose. The neuraminidase-
treated proteins showed a lower aggregation than did the native pro-
teins (Figures 33cand 34c). Previously, Solum and Stormorken (152) 
also showed the same results that ADP-induced platelet aggregation was 
drastically reduced with incubation of neuraminidase-treated fibrino-
gen. Even if neuraminidase-treated proteins cause the highest release 
of serotonin, their effect on ADP-induced aggregation was not corres-
pondingly increased, which means that the release during the aggrega-
tion period is not potent enough to affect or accelerate the ADP-
induced aggregation. This can be confirmed by Figures 33 and 34, 
which fail to show any second phase aggregation. The decrease of 
aggregating activity may be caused by conformational changes of proteins 
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in solution upon the removal of negatively charged sialic acid. Re-
moval of sialic acid may be responsible for enhancement of ADP-induced 
platelet aggregation. It has been reported that sialic acid ;s im-
portant in the fibrinogen-fibrin transition (219). Clots obtained 
from sialic acid-free fibrinogen are unstable and are dissolved in 
6 M urea. 
The importance of the sugar residues of glycoproteins in plate-
let aggregation is also revealed using periodate-treated fibrinogen 
and gamma-globulin. The sugar part of the proteins was selectively 
oxidized with periodate under mild conditions, at pH 7.0 in a 0.01 N 
periodate as described in the experimental section. As a result of 
the oxidation of the sugar moiety, fibrinogen loses its clotting 
ability by the action of thrombin. This indicates that the intact 
carbohydrate moiety is needed for the proper clotting of fibrinogen. 
It is demonstrated in Figures 35 and 36 that periodate-treated proteins 
fail to effect ADP-induced aggregation of washed bovine platelets. The 
loss of platelet aggregability by the oxidation of the carbohydrate 
moiety emphasizes the importance of carbohydrate integrity in pletelet 
aggregation by the glycoproteins. With only a one-hour periodate 
treatment of the glycoproteins, their enhancing effect of ADP-induced 
platelet aggregation is sharply decreased (Figures 35b and 36b). A 
three-hour treatment completely removes the enhancing effect of ADP-
induced aggregation (Figures 35c and 36d). A possible change of pro-
tein conformation, which will be discussed later~ may cause this re-








Figure 35. Effects of periodate treated fibrinogen on ADP-induced 
aggregation of washed bovine platelets (Final concentra-
tion of ADP, 5 x 10- 6 M; Final concentration of protein, 
0.74 mg/ml): (a) Native; (b) One hour or two hour 
treated; (c) Three hour treated; (d) Buffer. The 
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TIME (MIN) 
Figure 36. Effect of periodate treated y-Globulin on ADP-induced 
aggregation of washed bovine platelets (final concen-
tration of ADP, 5 x 10-6 M; Final concentration of 
protein, 0.74 mg!ml): (a) Native, (b) One hour 
treated, (c) Two hour treated, (d) Three hour treated 
or buffer. The condition of periodate treatment, 
pH 7.0, 0.01 N Nal04, Room temperature. 
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The effect of the conformational change of the glycoproteins 
on platelet aggregation was observed using U.V. treated proteins. 
The plasma proteins, fibrinogen and gamma-globulin, were denatured 
under a U.V. lamp for six hours before it became cloudy. The effects 
of U.V. denatured fibrinogen and gamma-globulin on platelet aggrega-
tion are shown in Figures 37 and 38. The enhancing effect of the 
platelet aggregation by the U.V. treated proteins was significantly 
reduced (b). The deantured proteins showed conformational changes 
upon U.V. irradiation based on their circular dichroism spectra which 
will be discussed in a later section. 
Figure 39 shows plasmin-treated fibrinogen (mixture of frag-
ments 0 and E) on ADP-induced platelet aggregation. Each structure of 
fibrinogen fragments D and E in original fibrinogen are retained even 
after degraded into E and D by a limited proteolysis (220). When the 
mixture of fragments 0 and E was added to washed platelets instead of 
fibrinogen prior to the addition of ADP, it failed to enhance platelet 
aggregation (Figure 3gb). This result indicates that the core frag-
ments D and E themselves may not be responsible for the enhanced 
platelet aggregation though all the carbohydrates of fibrinogen are 
localized on the 0 and E fragments. 
The effects of several compounds such as aspirin, UDP, gluco-
samine and chlorpromazine upon ADP-induced platelet aggregation is 
shown in Figure 40, Chlorpromazine was suspended (lO~3 M) in isotonic 
phosphate buffer with pH 7~4 adjusted. The other three drugs were 
-1 dissolved in isotonic phosphate buffer in a concentration of 10 M 
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Figure 37. Effect of U!V~ treated fibrinogen on ADP~induced aggrega-
tion of washed bovine platelets (Final concentration of 
ADP, 5 x lO~6 M; Final concentration Qf protein, 0.74 

















Figure 38. Effect of UV treated I-Globulin on ADP-induced aggrega-
tion of washed bovine platelets (Final concentration of 
ADP, 5 x 10-6 M; Final concentration of protein, 0.74 
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TIME (MiN) 
Figure 39. Effect of plasmin treated fibrinogen (Fragments, D + E) 
on ADP-induced aggregation of washed bovine platelets 
(Final concentration of ADP) 5 x 10- 6 M; Final concen-
tration of protein, 0.74 mg/ml): (a) Native fibrinogen, 

















o 2 4 6 
TIME (MIN.) 
Effect of drugs on ADP-induced aggregation of bovine PRP 
(Final concentration; ADP 5 x 10-6 M): (a) Without 
drug, (b) A~p;rin, 10-2 M; (c) Chlorpromazine, 10-4 ivt 
and UDP, lO-L ~i. 
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was added to 0.5 ml of platelet rich plasma. A volume of 20 ~l of 
ADP (1.25 x 10-4 M) was added as an aggregating agent. All drugs 
but glucosamine inhibited the ADP-induced platelet aggregation in 
platelet rich plasma (PRP) at a final concentration of 10-2 M for 
aspirin, UDP and glucosamine, and 10-4 M for chlorpromazine. Gluco-
samine failed to inhibit the ADP-induced aggregation. These com-
pounds are known to inhibit the glycoprotein-g1ycosy1transferase 
reaction. Feutin-sialyltransferase has been inhibited 80 percent, 95 
percent, and 97 percent by D-g1ucosamine, aspirin, and UDP at a 10-2 
M final concentration, respectively (48). Glucosyltrunsferase has 
also been inhibited by aspirin, chlorpromazine, and glucosamine. 
Paralleling the inhibition of glycosyltransferases, these drugs have 
shown an inhihition of platelet adhesion onto collagen (50) and onto 
fibrinogen- or gamma-globulin-coated polymer surfaces (20). But 
glucosamine has been noted to be a weak inhibitor of platelet adhe-
sion onto the protein coated surface. The inhibition activity shown 
by these drugs and previous related data are supportive of the pos-
sible involvement of the glycosyltransferase reaction in platelet 
adhesion and aggregation. 
7.5 Retention of Platelets in the Protein- and 
Galactose-Immobilized Beads in Columns 
Three experiments were carried out using the same source of 
bovine blood. Citrated blood was passed through columns containing 
Sepharose 2B-glycine, -proteins, and -galactose. The results are 








































































































































































































































































































































































































































































































































































column fractions was defined as the percent retention. Standard de-
viations for the mean percent retention of each fraction ranged from 
2 to 11. Paired t-tests between any two different beads indicated a 
significant difference (P < 0.01) between platelet retention by one 
kind of bead and by another. Though the retention values of plate-
lets in a given fraction vary with blood samples, overall trends of 
retention show consistency. The use of fibrinogen- or gamma-globulin-
immobilized beads produced a marked increase in platelet retention, 
as demonstrated in Figures 41 and 42. However, oxidation of the 
terminal galactose of the glycoprotein oligosaccharide chains showed 
significantly decreased retention values. When the immobilized 91y-
coproteins were treated with neuraminidase in order to expose more 
galactose to the terminus, platelet retention was significantly in-
creased compared to the native proteins. These results are consis-
tent with the previous platelet interaction data, that more platelets 
can interact wiht the glycoproteins with increased numbers of terminal 
galactose. Figure 43 shews platelet retention on galactose immobi-
lized beads. Galactose was immobilized as described in the experi-
mental section. ~~hen galactose was immobilized to Sepharose 28, the 
retention in the beads was markedly increased. Another evidence of 
interaction of galactose units with platelets was the case in which 
4 ml of PRP and 2 gm of wet galactose beads were incubated for 
20 minutes at 37°C. The decrease of platelet count in PRP was 22 
percent compared to three - four percent in albumin- or glycine-
immobilized beads. It has been reported that there were formed large 









































































































































































aggregates of cultured fibroblasts to galactose-Sephadex beads, con-
taining beads and cells, while no such aggregates were observed in 
the presence of Sephadex itself or glucose-Sephadex beads (221). 
Along with this previous work, the results suggest an involvement of 
galactose in platelet glycoprotein interactions. 
7.6 Platelet Adhesion onto Protein-Coated Surfaces 
It has been known that platelet adhesion onto albumin-coated 
surface is minimal, while fibrinogen or gamma-globulin-coated sur-
faces induce an increased number of platelet adhesion. These phe-
nomena were observed microscopically as shown in Figures 44 through 
50. Platelets are barely found on albumin-coated surfaces as demon-
strated in Figure 44. Fibrinogen and gamma-globulin-coated surfaces 
show relatively large numbers of adhered platelets. On the other 
hand, oxidation of terminal galactose of adsorbed glycoproteins 
caused platelet adhesion at a level seen with albumin-coated surfaces 
(Figures 45c, 46c). Neuraminidase-treated fibrinogen (Figure 45b) 
and gamma-globulin (Figure 46b) coatings enhanced platelet adhesion. 
Light microscopy observations (Figures 47 and 48) are consistent 
with scanning electron micrographs. Nonprotein-coated surfacase used 
as controls did not show decreased or increased platelet adhesion by 
galactose oxidase or neuraminidase treatement respectively (Figure 
51). The importance of sugar units in glycoprotein-platelet inter-
action is demonstrated in Figures 49 and 50. The glycoproteins lost 
their reactivity to interact with platelets by the periodate oxida-
tion of their sugar units. A one-hour oxidation was able to change 
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Figure 44a. Scanning electron micrograph of platelet adhesion onto 
albumin coated r~ylar surface: 1000 x. 
Figure 44b. Light micrograph of platelet adhesion onto albumin 
coated f1yl ar surface: 1500 x. 
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Figure 45a. Scanning electron micrograph of platelet adhesion onto 
fibrinogen coated t,1ylar surface: 1000 x. 
Figure 45b. Scanning electron micrograph of platelet adhesion onto 
r~lar surface coated with neuraminidase-treated fibrino-
gen: 1000 x. 
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Figure 45c. Scanning electron micrograph of platelet adhesion onto 
t·1yl ar surface coated with galactose oxi dase-treated 
fi bri nogen: 1000 x. 
Figure 46a. Scanning electron micrograph of platelet adhesion onto 
y-globulin coated Mylar surface: 1000 x. 
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Figure 46b. Scanning electron micrograph of platelet adhesion onto 
r~ylar surface coated with neuraminidase-treated Y-globu-
1 in: 1000 x. 
Figure 46c. Scanning electron micrograph of platelet adhesion onto 
r1ylar surface coated with Galactose oxidase-treated 
y-globulin: 1000 x. 
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Figure 47a. Light micrograph of platelet adhesion onto fibrinogen 
coated r'1yl ar surface: 1500 x. 
Figure 47b. Light micrograph of platelet adhesion onto Mylar sur-
face coated with neuraminidase treated fibr i nogen 
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Figure 47c. Light micrograph of platelet adhesion onto r1ylar surface 
coated with galactose oxidase-treated fibrinogen: 1500 x. 
Figure 48a. Lig ht micrograph of platelet adhesion onto y.globulin 
coated ~'1ylar surface: 1500 x. 
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Figure 48b. Light migrograph of platelet adhesion onto y-globulin 
coated r'1ylar surface: 1500 x. 
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Figure 48c. Light migrograph of platelet adhesion onto r'1y1ar surface 
coated with neuraminidase-treated y-globu1 i n: 1500 x. 
Fibure 48d. Light micrograph of platelet adhesion onto r~lar surface 




Light micrograph of platelet adhesion onto Mylar surface 
coated with periodate treated fibrinogen (1 Hour): 1500 x. 
Light micrograph of platelet adhes on onto r1ylar surface 




Light micrograph of platelet adhesion onto 11ylar surface 
coated with periodate-treated y-globulin (1 Hour): 1500 x. 
Light micrograph of platelet adhesion onto t'1ylar surface 
coated with periodate-treated y- globulin (2 Hour): 1500 x. 
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Figure 51a. Light micrograph of platelet adhesion onto nonprotein 
coated f/lyl ar surface: 1500 x. 
Figure 51b. Light micrograph of platelet adhesion onto neuraminidase~ 
treated nonprotein coated Mylar surface: 1500 x. 
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Figure 51c. Light micrograph of platelet adhesion onto galactose 
oxidase-treated nonprotei n coated r'ly-1 ar surface: 1500 x. 
Figure 51d. SEM of platelet adhesion onto nonprotein coated r ~lar 
surface: 1000 x. 
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the behavior of these adsorbed glycoproteins to an albumin-like be-
havior resulting in little platelet adhesions. These results are 
supportive of the proposed mechanism in which terminal galactose 
units of incomplete oligosaccharide chains are responsible for the 
platelet-protein interaction. 
7.7 Circular Dichroism 
It was previously demonstrated that the treatment of fibrino-
gen and gamma-globulin with ultra-violet radiation caused conforma-
tional changes and the use of these proteins showed a reduction of 
ADP-induced platelet aggregation. The conformational change was con-
firmed by circular dichroism spectrum of the UV treated fibrinogen 
sho\'Jn in Figure 52. An average was taken from three runs to calcu-
late the ellipticity at each wavelength, and the results are reported 
in terms of [8J, the mean residue ellipticity in units of deg. cm2; 
dmole. The far ultraviolet CD spectrum of UV treated fibrinogen is 
qualitatively similar to that of native fibrinogen, but the mean 
residue ell ipticities ~"ere markedly decreased at all wavelengths. It 
was also discussed previously that neuraminidase-treated fibrinogen 
and gamma-globulin caused less platelet aggregation than expected, 
which may be due to conformational changes. It is demonstrated in 
Figure 53 that the conformation of neuramir:idase-treated fibrinogen 
is significantly different from that of native fibrinogen, while the 
galactose oxidase-treated fibrinogen maintained its conformational 
integrity.. The effect of periodate treatment of fibrinogen conforma-
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Figure 52. Circular dischroism spectra of native and 
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Figure 53. Circular dichroism spectra of native and enzyme treated 
fibrinogen: (a) Neuraminidase treated, (b) Native, 
(c) Galactose oxidase treated. 
-8 
200 
\ /.' \ a ,~ .. 
\ ~.."" ~ .... -.~ .. , , . 







Wave length (nm) 
240 
Figure 54. Circular dichroism spectra of periodate treated 
fibrinogen: (a) Three-hour treated, (b) Two-




has little effect on its conformation, the CD spectrum is markedly 
changed with a three-hour treatment. The trough at 222 nm seems to 
disappear with the periodate treatment. The reduced platelet aggre-
gation by the periodate treated proteins may be due to both conforma-
tional change and removal of the carbohydrate moieties. A one-hour 
treatment, though little conformational change could be observed, 
reduced the platelet aggregation and release, which is mainly due to 
the removal of carbohydrates. 
Wavelengths of troughs and respective values of mean residue 
ellipticities [e] are listed in Tables 11 and 12. The trough of 
fibrinogen at 222 nm appeared to be shifted towards a shorter wave-
length or disappeared upon denaturation. The helix content was ca1-
cu1ated in three different methods. In the first method, the follow-
ing reference parameters were used: -38000 and +3000 degrees.cm2. 
decimole-1 for the mean residue ellipticity at 222 nm for 100 per-
cent a-helix and random coil conformation respectively (222). The 
second method ultilized Fasman1s approximate formula at 208 nm wave-
length (177), The third method, Myer1s simplified method, is similar 
to the second method in calculating a-helix content but uses differ-
ent parameters (178). 
Earlier reports of the helical content of fibrinogen, using 
optical rotatory dispersion data (80) and circular dichroism data 
(222), showed a range of 30 - 34 percent. The first calculation at 
222 nm has the closest value to this range of helix content of native 
fi bri nag en. He 1 ; x content of fi bri onogen ~I/as dec reased VJi th UV, 





























































































































































































































































































































































































































































































































































































































7.8 Involvement of Enzyme Reaction Mechanism in Plate1et 
Aqgregation, Adhesion, and Release 
158 
It has been demonstrated by others that glycosyltransferases 
are important for the synthesis of glycoproteins as well as for cell 
adhesion. A generalized role for membrane glycosyltransferases and 
their substrates in intercellular adhesion was initially proposed by 
Roseman (47). This concept has gained further credence by the identi-
fication of these enzymes on the outer membranes of a number of cells 
such as embryonic cells (223), tissue culture cells (224), blood 
platelets (48-50~12l,122) and intestinal cells (225). Platelet adhe-
sion was described using this concept of the glycosyltransferase 
forming a complex with the substrate (48). A mechanism for platelet 
adhesion to collagen has also been proposed invovling glycosyltransfer-
ase present on the outer surface of the platelet membrane forming a 
complex with the incomplete carbohydrate chains of collagen (50). 
The galactosyl residue of collagen may be involved in the adhesion 
of blood platelets to collagen. This enzyme mechanism is supported 
by the fact that collagen-induced platelet aggregation can be pre-
vented by oxidation of the hydroxymethyl group of the galactosyl 
residue in collagen to an aldehyde using galactose oxidase. Platelet 
aggregation resumes after the reductior. of the aldehyde group with 
sodium boro~ydride (51). The importance of the carbohydrates of col-
lagen \'1as also revealed by using periodate treated collagen (226). 
Oxidation of the collagen with sodium periodate reduces its ability 
to interact with platelets. Cazenave, et a1., (227) disagreed with 
this mechanism because the inhibitors of glucosyltransferase reaction 
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such as UDP and glucosamine, failed to inhibit platelet adhesion on 
collagen. Jamieson, et al., (228) subsequently proposed that plate-
let adhesion represents only the first step of the enzyme reaction; 
that is, the formation of the enzyme-substrate complex. In other 
words, inhibitors may not cause inhibition of the enzyme-acceptor 
complex. 
Bovine factor VIII aggregates human platelets by a similar 
mechanism (229). Exposure of bovine factor VlrI to galactose oxidase 
completely abolishes its aggregating property. Human factor VIII 
devoid of the aggregating activity also produces strong aggregating 
activity when treated with neuraminidase. This suggests that the 
interaction of galactose containing side chains in bovine factor VIII 
or the neuraminidase-treated human factor VIII with the platelet 
~embrane is the trigger for the platelet aggregation brought about 
by this protein. Human factor is able to agglutinate or aggregate 
normal human platelets in the presence of ristocetin (von Wil1ebrand 
factor). Removal of > 95 percent of the sialic acid from the protein 
by neuraminidase does not affect the von Wi1lebrand factor or pro-
coagulant activity. However, subsequent oxidation of the penultimate 
galactose of the factor protein with galactose oxidase results in a 
progressive loss of von Wil1ebrand activity with no effect on pro-
coagulant activity (230). Reduction of the 6-a1dehydo intermediate 
by sodium borohydride causes full regeneration of von Wi11ebrand fac-
tor activity, indicating the importance of galactose moiety as a 
critical determinant of von Willebrand factor activity. 
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Von Willebrand's disease is an autosomally trans~itted bleed-
ing disorder in which the level of antihemophilic factor (AHF, fac-
tor VIII) in blood is decreased and the bleeding is prolonged (231). 
The factor VIII/von Willebrand factor protein obtained from patients 
v/ith von Willebrand's disease is deficient in both carbohydrate con-
tent and von Willebrand factor activity. It suggests that the carbo-
hydrate portion of the protein is of major importance in its inter-
action with platelets and von Willebrand activity (232). 
Bosman has shown that sialyltransferase is present on the 
platelet membrane and that the enzyme activity can be inhibited by 
aspirin and UDP (48). He proposed a model to explain his conceptual 
view as to how sialyltransferase might mediate cell adhesion and dis-
adhesion. In this model, sialyltransferase on one cell interacts with 
a glycoprotein acceptor, exposed galactose terminus on another cell 
to form a complex. In analogy to this model, this dissertation con-
siders a possibility that sialyltransferase on the platelet membrane 
may also interact with plasma glycoproteins such as fibrinogen and 
gamma-globulin as acceptors. The evidence has been seen from the 
binding of desialylated glycoproteins by s;alyl~ransferase on plasma 
membrane of rat liver cells (233). 
The enzyme activity of sialyltransferase on the platelet mem-
brane is stimulated by aggregating agent and depressed by aggregation 
inhibitors (234). ADP-induced aggregation of PRP is depressed with 
sialyltransferase inhibitors such as aspirin and UDP. This is sup-
portive of the proposed mechanism in platelet-protein interaction. 
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All the experimental results are consistent with the proposed 
enzyme mechanism. However, it should also be pointed out that lectin-
lectin receptor interaction has been hypothesyzed as a mechanism for 
cell-cell recognition and interaction. Lectin activity has recently 
been demonstrated on the platelet membrane (235). Human platelet 
membrane has the greatest activity against cow erythrocytes, but also 
significant activity against human erythrocytes. The platelet mem-
brane lectin activity has been found to reside in protein molecules 
on the external surface of the platelet plasma membrane. Thrombin 
stimulation of platelets causes an alteration in the membrane surface 
that results in the parallel expression of enhanced lectin activity 
and membrane cohesiveness (236). The lectin activity ;s inhibited 
by hexosamine but not by neutral sugars. Whether the lectin activity 
is related or linked to the enzyme activity is unclear and requires 
further study. 
8. SUMMARY AND CONCLUSIONS 
Thrombus formation at blood interfaces has been a critical 
factor in the design of medical devices and artificial organs. In-
vestigators have agreed that foreign surfaces adsorb plasma proteins 
upon blood contact and these proteinated surfaces may determine the 
platelet adhesion and consequent thrombus formation. Platelets show 
little adherence to an albumin preccated surface, while a fibrinogen 
or a gamma-globulin coated surface has an increased number of adher-
ing platelets. These latter glycoproteins have oligosaccharide chains 
linked to their peptide chains, while albumin does not contain such 
oligosaccharide chains. 
It has been proposed that the glycoproteins such as fibrino-
gen and gamma-globulin may interact with platelets via enzyme-substrate 
complex formation. Glycosyltransferase present in the platelet me~­
!:it'ane can form the enzyme-substrate complex with the incompl ter-
minal sugar units such as galactose and N-acetylglucosamine. But the 
detailed enzyme mechanism to verify directly the hypothesis is not 
feasible due to the limitations of the technique involved in the 
enzyme assay. 
In this disseration, several experiments were accomplished to 
support the hypothesis in which heterosaccharide groups of glycopro-
teins play an important role in protein-platelet interactions. The 
results summarized as llows indicate a possible glycosyltransfe~ase 
reactions in the platel interactions. 
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1. Protein adsorption: Protein adsorption is dependent on 
polymer nature. The adsorption of plasma proteins can be related 
with thrombogenicity of polymers. Albumin adsorption is especially 
greater than fibrinogen or gamma-globulin on a relatively nonthrom-
bogenic polymer. Therefore, the mole ratio of adsorbed fibrinogen 
or gamma-globulin to adsorbed albumin may be used for the thrombo-
genicity index. Polymers with low ratio values, as shown with Biomer 
and Avcothane, are known to be blood tolerable polymers when compared 
with other' commercial polymers. These results emphasize the involve-
ment of the glycoproteins in thrombus formation. 
2. Interaction of platelets with glycoproteins: Platelets 
interact with fibrinogen and gamma-globulin due to the incomplete 
terminal sugars s~ch as galactose and fJ-acetylglucosamine. One of 
the incomplete terminal sugars, galactose, is abundant in fibrinogen 
and gamma-globulin. This galactose governs the binding activity of 
the proteins with platelets. Neuraminidase treatment of glycopro-
teins which exposed more available galactose to a terminal position 
caused an increase in the protein binding reactivity. Oxidation of 
the C-6 carbon of the terminal galactose unit in the glycoproteins 
reduced the binding capacity. These results are consistent with the 
proposed mechanism considering the facts that complex formation in-
creases with increasing concentration of the terminal ga1actose and 
the binding is saturated at a certain concentration of proteins. 
3. Serotonin release from platelets: Platelet serotonin 
release was increased with increasing protein binding to platelets. 
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The neuraminidase treated glycoproteins increased the serotonin re-
lease due to the greater binding, while galactose oxidase treated 
glycoproteins reduced the release with less binding. The fact that 
gamma-globulin is stronger release agent than fibrinogen, though 
fibrinogen shows stronger interaction with pletelets than does gamma-
globulin, suggests an additional factor such as a structural require-
ment for the release. ~Jith periodate treatment, the glycoproteins 
lose carbohydrates and further treatment results in conformational 
change of the glycoproteins. Glycoproteins fail in inducing seroto-
nin release by the loss of carbohydrates. 
4. Platelet aggregation: Effect of the proteins of ADP-
induced aggregation was changed by the enzyme treatments. Galactose 
oxidase treatment reduced the aggregation effect due to the reduced 
interaction and release. Though the increased interaction and re-
lease was observed after neuraminidase treatment, however, the treat-
ment lowered the aggregation effect. This indicates conformational 
changes of the proteins after neuraminidase treatment which was con-
firmed by circular dichroism spectrum. The reduced aggt"egation effect 
according to the conformational changes was also observed using UV 
treated proteins. Periodate treatment of the proteins also reduced 
the effect of platelet aggregation depending upon the duration of the 
treatment. This may be caused both by loss of carbohydrates and by 
conformational change. The confonnation of fibrinogen \'/as continu-
ously changed with incr~ases in the periodate treating time, which 
was confirmed by the circular dichroism spectra. 
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5. Platelet retention: As expected from the platelet in-
teraction data, more platelets were retained ;n the columns contain-
ing neuraminidase treated proteins and less platelet retention with 
galactose oxidase treated proteins. The importance of galactose was 
strengthened by using galactose-immobilized beads. The interaction 
of beads with platelets VIas increased when galactose was immobilized 
to the beads. Platelet retention was also increased with the use 
of these galactose immobilized beads. 
6. Platelet adhesion onto protein coated surface (direct 
observation of protein-platelet interaction using SEM and light micro-
scope): Increased numbers of adhered platelets were shown on the 
fibrinogen or gamma-globulin coated surfaces. The increased terminal 
galactose by neuraminidase treatment promoted platelet adhesion. 
Galactose oxidase treatment of the adsorbed proteins changed the 
platelet adhesion to a 1evel equal to that of the albumin-coated sur-
face. Periodate treatment which selectively oxidizes only carbo-
hydrate portions of the glycoprotein completely changed the surface 
into a nonp~atelet adhesive surface. 
These results are consistent with the proposed mechanism. 
Furthermore, the sialyltransferase inhibitors such as aspirin, UDP, 
and chlorpromazine have depressed ADP-induced aggregation of PRP, 
strengthening the involvement of glycosyltransferase in protein-
platelet interactions. It is also known that the activity of sialyl-
transferase on the platelet membrane is stimulated by platelet aggre-
gating agents and depressed by aggregation inhibitors. 
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Conclusively, the terminal sugar residue of incomplete oligo-
saccharide chains is important in platelet-protein interactions and 
subsequent reactions of aggregation and release. A terminal sugar 
residue, galactose, may form an enzyme-substrate complex with sialyl-
transferase on the platelet membrane, and then induce the release of 
serotonin and cause platelet aggregation. However, a structural 
specificity is probably required for maximal release or aggregation. 
Therefore, a conformational change of the glycoproteins may contribute 
significantly to the subsequent reactions after binding of the pro-
teins with platelets. 
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